Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3045684	s-afmakro	U/l (u/l)	2136	2675	0.00%
3045684	s-afmakro	— (—)	489	523	100.00%	Distribution not available
3045684	s-afmakro	U/l_______ (u/l)	147	164	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

704

1302

4.97

310.07

1.3

1.2

23.96

22.49

u/l

0.26

611

1094

Dialysis, with operation codes

294

232

13.32

305.80

1.5

1.2

39.16

21.68

u/l

3.28

263

188

Diseases of liver

521

873

6.12

296.00

1.3

1.2

34.57

21.20

u/l

3.72

465

712

Chronic kidney disease

453

694

6.43

266.68

1.4

1.3

31.99

25.59

u/l

1.19

396

557

Nephropathy related operations

276

247

11.74

265.09

1.5

1.2

39.06

24.55

u/l

2.26

248

204

Renal failure

584

1008

5.02

254.39

1.3

1.2

35.80

26.25

u/l

2.54

511

826

Care involving dialysis

207

140

15.68

235.55

1.5

1.2

27.81

22.04

u/l

0.67

185

109

Transplanted organ and tissue status

220

168

13.75

233.30

1.4

1.1

29.46

22.32

u/l

0.72

197

136

All chronic kidney diseases

598

1051

4.60

230.34

1.3

1.2

32.30

22.76

u/l

3.02

524

873

L04AD Calcineurin inhibitors

232

219

11.09

214.85

1.4

1.2

26.17

21.89

u/l

0.45

206

179

Autoimmune diseases excluding thyroid diseases

855

1289

3.63

211.07

1.3

1.2

26.47

26.50

u/l

0.00

747

1066

Autoimmune diseases excluding thyroid diseases, strict definition

824

1230

3.67

207.49

1.3

1.2

26.08

26.21

u/l

0.02

722

1014

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

843

1689

3.39

204.82

1.3

1.2

30.06

24.16

u/l

1.68

736

1408

Renal tubulo-interstitial diseases

769

1646

3.46

197.16

1.3

1.2

34.18

22.63

u/l

4.68

671

1372

Anaemias

233

121

12.53

181.33

1.3

1.2

29.09

12.52

u/l

4.55

205

ILD medications

843

1416

3.23

176.25

1.3

1.2

27.20

23.43

u/l

0.80

721

1197

All kidney diseases

789

1667

3.20

174.62

1.3

1.2

31.92

22.35

u/l

3.72

682

1397

L04AA Selective immunosuppressants

319

555

5.89

174.61

1.3

1.2

28.69

22.33

u/l

0.83

281

450

Fibrosis and cirrhosis of liver

181

162

11.77

173.99

1.5

1.1

32.46

20.54

u/l

1.35

166

135

ILD medications: prednisolone, methylprednisolone, prednisone

807

1405

3.22

169.38

1.4

1.2

28.59

23.58

u/l

1.10

682

1187

Autoimmune diseases related-to ILD

716

1888

3.19

168.93

1.3

1.2

26.29

25.38

u/l

0.14

617

1590

First line medication for Crohn's disease

805

1358

3.21

166.65

1.3

1.2

29.52

22.20

u/l

1.89

688

1133

Preparatory care for dialysis

134

18.82

166.15

1.4

1.2

27.12

23.69

u/l

0.29

118

Bacterial infection, other or unspecified, including avohilmo

556

1231

3.74

165.77

1.3

1.2

41.40

21.03

u/l

8.34

514

1004

Bacterial infection, other or unspecified

522

1164

3.83

162.09

1.3

1.2

42.86

21.62

u/l

8.13

483

947

Other bacterial diseases

766

1644

3.11

161.77

1.3

1.2

38.43

20.13

u/l

8.34

680

1353

Other diseases of liver

271

444

6.27

157.88

1.3

1.2

33.27

18.97

u/l

2.41

240

362

Primary biliary cholangitis, wide definition

36.46

154.81

1.6

1.0

29.86

12.12

u/l

1.54

IBD patients in KELA-register

277

480

5.88

152.10

1.4

1.2

20.64

22.00

u/l

0.12

231

400

Other bacterial diseases, including avohilmo

776

1638

2.98

149.83

1.3

1.2

36.03

19.32

u/l

7.53

689

1351

Inflammatory bowel disease treatment related agents

833

1599

2.91

148.68

1.3

1.2

27.30

24.75

u/l

0.45

707

1354

ILD medications: azathioprine

199

250

8.16

147.83

1.4

1.2

26.91

23.18

u/l

0.24

170

206

Kidney transplant status

135

14.65

147.78

1.5

1.2

22.32

17.79

u/l

0.65

117

Heart failure, not strict

631

1301

3.29

146.36

1.3

1.2

32.64

21.71

u/l

4.16

546

1071

Primary biliary cholangitis (PBC)

33.90

145.21

1.5

1.1

29.36

15.00

u/l

1.04

Inflammatory bowel disease, strict (require KELA)

277

502

5.63

145.06

1.4

1.2

20.64

22.50

u/l

0.17

231

421

Tramadol

628

1165

3.27

138.97

1.3

1.2

31.76

21.36

u/l

3.28

537

983

Extracorporeal dialysis

138

115

12.66

138.95

1.6

1.2

26.78

20.16

u/l

1.08

123

100

Azathioprine

199

272

7.49

137.50

1.4

1.2

26.91

23.44

u/l

0.23

170

225

5-aminosalicylic acid

248

428

5.90

136.77

1.4

1.2

22.09

20.94

u/l

0.09

208

358

Examination and observation for other reasons

498

745

3.81

133.61

1.2

24.37

25.54

u/l

0.14

436

624

Mucosal proctocolitis

183

236

7.96

133.08

1.4

1.2

23.91

20.91

u/l

0.22

154

191

Glomerular disorders in diseases classified elsewhere

182

237

7.93

131.42

1.5

1.2

33.22

26.18

u/l

0.77

169

195

Second line medication for Crohn's disease

514

1592

3.26

131.31

1.3

1.2

22.41

24.70

u/l

0.41

444

1334

Dental caries

284

540

5.04

129.37

1.3

1.2

33.54

25.21

u/l

1.26

256

447

Bacterial Sepsis

449

1032

3.64

129.05

1.4

1.2

36.77

24.01

u/l

3.77

400

859

Noninfective enteritis and colitis

429

1208

3.59

127.41

1.4

1.2

23.33

23.68

u/l

0.04

361

996

Inflammatory bowel disease

328

770

4.32

126.27

1.4

1.2

22.04

22.39

u/l

0.03

275

639

Glomerular diseases

227

396

5.86

124.00

1.4

1.2

31.46

24.54

u/l

0.92

207

325

Primary Sclerosing Cholangitis, IBD and UDCA required

28.88

123.48

1.4

1.2

35.20

13.63

u/l

1.46

Implicit bacterial Sepsis

402

927

3.76

122.61

1.3

1.2

38.91

23.64

u/l

4.46

357

767

Budesonide

194

297

6.69

120.81

1.5

1.2

21.79

22.82

u/l

0.08

165

249

Septicaemia

385

940

3.78

120.29

1.3

1.2

38.11

22.02

u/l

4.24

344

760

Autoimmune diseases

722

1302

2.83

119.54

1.3

1.2

25.76

26.35

u/l

0.08

623

1075

Acute renal failure

242

471

5.23

117.18

1.3

1.2

46.57

22.88

u/l

4.63

215

369

Caries of dentine

252

485

5.09

116.99

1.3

1.2

33.28

24.79

u/l

1.20

227

399

Ulcer of lower limb, not elsewhere classified

196

317

6.34

115.73

1.4

1.2

36.45

23.25

u/l

2.42

175

257

L04AX Other immunosuppressants

484

1562

3.13

115.60

1.3

22.42

24.58

u/l

0.36

419

1311

Implicit bacterial Sepsis, including avohilmo

420

1006

3.51

114.87

1.3

1.2

39.15

23.79

u/l

4.40

372

837

Other septicaemia, including avohilmo

352

865

3.86

114.58

1.3

1.2

39.03

22.42

u/l

3.99

316

693

Disorders resulting from impaired renal tubular function

101

15.45

113.57

1.5

1.2

21.72

18.95

u/l

0.29

Abnormal findings on examination of blood, without diagnosis

411

1086

3.46

112.73

1.3

1.2

31.49

28.01

u/l

0.50

360

895

Explicit Sepsis, including avohilmo

401

1045

3.52

112.67

1.3

1.2

37.55

22.43

u/l

4.08

359

870

Other septicaemia

343

849

3.85

111.41

1.3

1.2

38.49

22.58

u/l

3.63

307

679

Polyarthropathies

538

1134

3.07

110.53

1.3

25.25

27.57

u/l

0.42

463

952

Explicit Sepsis

391

1021

3.53

110.47

1.3

1.2

37.82

22.67

u/l

3.93

349

851

Persons encountering health services for specific procedures and health care

735

1675

2.60

109.78

1.4

1.2

30.17

22.14

u/l

2.28

646

1392

Unspecified kidney failure

151

197

7.88

108.82

1.2

1.3

32.49

24.64

u/l

0.80

128

163

Reimbursement for rheumatic diseases

477

1615

2.96

103.65

1.3

1.2

23.06

24.61

u/l

0.24

423

1339

Fever of other and unknown origin

431

1183

3.18

102.45

1.4

1.2

36.61

21.87

u/l

4.75

386

978

Ulcerative colitis

251

567

4.50

101.67

1.4

1.2

22.51

23.23

u/l

0.06

209

470

Used for control exclusion in common control thyroid runs

639

1171

2.77

101.55

1.3

1.2

25.29

26.74

u/l

0.20

554

965

Metabolic disorders

661

1522

2.62

100.50

1.3

1.2

28.23

25.44

u/l

0.47

560

1278

Dialysis

15.09

100.43

1.4

1.2

19.13

20.13

u/l

0.09

Aplastic and other anaemias

406

1183

3.17

97.28

1.3

1.2

33.34

27.24

u/l

1.30

350

977

Implicit Sepsis

564

1547

2.70

96.45

1.3

1.2

35.19

22.79

u/l

4.20

488

1288

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

199

388

5.22

96.28

1.5

1.2

20.83

23.44

u/l

0.19

168

326

Crohn disease

160

258

6.34

94.78

1.4

1.2

23.37

24.39

u/l

0.06

134

207

Any gastric operation

433

651

3.35

93.67

1.2

26.71

16.03

u/l

2.36

374

513

GASTRO-related operations

433

651

3.35

93.67

1.2

26.71

16.03

u/l

2.36

374

513

Other anaemias

382

1127

3.21

93.67

1.3

1.2

33.06

27.09

u/l

1.21

329

929

Ulcerative colitis (strict definition, require KELA)

189

361

5.34

93.62

1.5

1.2

21.21

23.46

u/l

0.15

159

301

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

185

347

5.44

93.51

1.5

1.2

21.57

23.57

u/l

0.13

156

288

Oral corticosteroids

672

1580

2.51

93.02

1.3

1.2

30.78

24.91

u/l

1.12

566

1337

Other and unspecified anaemias

378

1121

3.20

92.42

1.3

1.2

33.05

27.17

u/l

1.17

325

924

Other Crohn's disease

107

112

9.86

91.95

1.3

1.2

20.31

15.68

u/l

0.57

Implicit Sepsis, including avohilmo

582

1617

2.59

90.67

1.3

1.2

34.49

22.04

u/l

4.42

498

1352

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

177

330

5.48

90.16

1.3

1.2

41.42

21.45

u/l

3.68

163

264

Abnormal serum enzyme levels

263

646

3.98

89.96

1.3

33.15

28.01

u/l

0.65

226

528

Pneumonias (Asthma/COPD co-morbidities)

677

1838

2.42

89.66

1.3

1.2

36.25

21.03

u/l

5.78

593

1542

Secondary hypertension

108

117

9.33

88.67

1.4

1.1

19.26

18.87

u/l

0.04

All pneumoniae

679

1845

2.40

88.63

1.3

1.2

36.14

21.06

u/l

5.71

595

1548

Cholangitis (primary sclerosing, PSC)

107

118

9.40

88.51

1.3

1.2

39.54

17.48

u/l

1.87

Any reimbursement code in KELA

284

321

4.46

88.14

1.2

1.1

26.96

17.05

u/l

1.21

249

260

Heart failure,strict

391

865

3.18

87.46

1.3

1.2

36.10

23.14

u/l

3.60

340

699

Osteopathies and chondropathies

460

1525

2.78

87.41

1.4

1.2

26.75

24.23

u/l

0.48

394

1271

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

651

1705

2.43

86.02

1.3

1.2

27.59

24.57

u/l

0.54

557

1430

Insulin, intermediate and long-acting

414

1396

2.89

85.38

1.3

34.23

25.55

u/l

2.28

370

1164

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

596

1622

2.49

84.99

1.3

1.2

33.24

21.41

u/l

4.27

515

1357

Insulin, fast-acting

299

874

3.46

84.20

1.3

1.2

36.75

23.29

u/l

3.15

269

714

Disorders of parathyroid gland

234

572

4.12

84.05

1.3

1.2

16.21

26.27

u/l

2.89

200

461

Influenza and pneumonia

684

1807

2.35

83.68

1.3

1.2

35.81

20.82

u/l

5.57

601

1513

Insulin, combination of fast acting with intermediate-acting or long-acting

452

1513

2.73

82.92

1.3

1.2

34.67

25.80

u/l

2.43

402

1264

Condition for Implicit Sepsis (Organ dysfunction codes)

578

1620

2.49

82.45

1.3

1.2

34.03

21.91

u/l

4.26

498

1354

Pneumonia, organism unspecified

609

1736

2.42

81.78

1.3

1.2

36.08

21.21

u/l

5.76

531

1449

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

652

1861

2.34

81.23

1.3

1.2

36.11

21.22

u/l

5.36

572

1560

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

598

1424

2.47

80.23

1.3

1.2

35.53

21.16

u/l

4.49

523

1190

598

1424

2.47

80.23

1.3

1.2

35.53

21.16

u/l

4.49

523

1190

Other disorders of kidney and ureter

158

296

5.46

80.12

1.4

1.2

19.90

23.70

u/l

0.59

136

243

Hyperparathyroidism

211

501

4.24

78.95

1.3

1.2

15.24

25.92

u/l

2.91

180

405

Diabetic nephropathy, excluding more controls

181

297

5.07

78.64

1.4

1.2

34.71

30.46

u/l

0.36

165

248

Insulin, fast-acting or short human

301

923

3.29

78.58

1.4

1.2

36.51

24.03

u/l

2.84

271

752

Insulin medication

452

1409

2.68

78.49

1.3

34.67

24.32

u/l

3.17

402

1172

Nonalcoholic fatty liver disease

142

246

5.93

78.39

1.2

30.53

23.70

u/l

0.41

120

197

Cholangitis (primary sclerosing, PSC), with reimbursement 202

20.98

78.00

1.3

1.2

34.23

13.60

u/l

0.93

Nutritional anaemias

399

1374

2.79

77.26

1.3

1.2

30.36

25.58

u/l

0.96

348

1135

Type 1 diabetes

215

536

4.05

76.37

1.3

34.18

22.85

u/l

1.76

198

437

Disorders of gallbladder, biliary tract and pancreas

647

1771

2.29

74.79

1.3

1.2

33.49

24.18

u/l

2.38

553

1483

Malaise and fatigue

379

1042

2.88

74.48

1.2

30.49

21.64

u/l

2.35

323

857

Ulcerative colitis, NAS

149

283

5.36

74.36

1.3

1.2

19.98

21.52

u/l

0.17

127

228

Diseases of arteries, arterioles and capillaries (FINNGEN)

208

330

4.40

72.58

1.3

1.2

27.00

24.27

u/l

0.24

176

275

Crohn's disease NAS

108

8.77

72.43

1.4

1.2

25.90

16.60

u/l

0.83

Type 1 diabetes, wide definition, subgroup 1

180

410

4.44

72.13

1.4

1.2

33.28

20.07

u/l

2.15

166

335

Diabetic nephropathy

184

423

4.39

71.76

1.4

1.2

35.58

28.73

u/l

0.86

168

362

Heart failure and antihypertensive medication

207

309

4.40

70.63

1.2

1.3

39.62

24.95

u/l

1.93

180

255

Implicit viral Sepsis, including avohilmo

251

736

3.44

70.24

1.3

1.2

39.28

23.28

u/l

3.00

217

599

Infections, IBD-co-morbidities

135

150

6.40

70.05

1.4

1.3

32.62

27.29

u/l

0.34

116

126

Certain infectious and parasitic diseases

555

1146

2.44

69.37

1.3

1.2

27.93

19.08

u/l

2.25

472

941

Heart failure, strict

419

1100

2.67

68.91

1.3

36.80

26.33

u/l

2.54

360

903

Iron deficiency anaemia

342

1196

2.83

68.43

1.3

1.2

31.26

25.12

u/l

1.24

300

990

Other and unspecified iron deficiency

285

923

3.11

67.83

1.3

1.2

30.06

25.38

u/l

0.79

251

752

Exposure to unspecified factor

645

2035

2.17

67.22

1.3

1.2

23.96

26.45

u/l

0.58

537

1736

Diseases of oesophagus, stomach and duodenum

652

1770

2.18

66.99

1.3

1.2

27.10

25.41

u/l

0.24

550

1500

General symptoms and signs

610

1344

2.28

66.33

1.3

1.2

27.09

21.26

u/l

1.56

524

1121

Erysipelas, including avohilmo

467

1417

2.46

66.23

1.3

1.2

33.30

20.62

u/l

3.88

396

1156

Autoimmune hepatitis, wide definition

10.64

66.16

1.3

1.1

26.35

17.70

u/l

0.59

Diseases of arteries, arterioles and capillaries

465

1399

2.45

65.60

1.3

1.2

34.69

26.20

u/l

1.58

399

1166

Acute tubulo-interstitial nephritis

413

1376

2.55

65.30

1.3

1.2

32.18

21.99

u/l

2.63

358

1134

Intestinal infectious diseases

599

2054

2.18

64.68

1.3

1.2

30.41

24.81

u/l

1.28

520

1728

Type 1 diabetes, wide definition

180

448

4.06

64.21

1.4

1.2

33.28

23.38

u/l

1.27

166

367

Other dialysis

12.49

63.92

1.5

1.2

21.14

21.60

u/l

0.03

Ulcerative colitis (strict definition, all Crohn cases excluded)

140

288

4.94

63.80

1.4

1.2

19.64

25.07

u/l

0.34

119

238

Erysipelas

373

1227

2.64

63.52

1.3

1.2

34.85

21.87

u/l

3.55

321

998

Disorders of other endocrine glands

338

1227

2.73

63.47

1.3

1.2

18.84

24.15

u/l

1.78

291

1020

Other heart diseases

294

614

3.13

63.06

1.3

1.2

25.75

21.70

u/l

0.60

259

523

All-cause Heart Failure

399

1086

2.57

61.31

1.2

1.3

36.69

26.39

u/l

2.33

342

890

Other diseases of intestines

609

1565

2.18

61.17

1.3

1.2

28.78

23.08

u/l

0.99

512

1326

Hypertensive diseases (excluding secondary)

314

609

3.02

61.15

1.2

20.73

21.89

u/l

0.13

267

516

Adjustment and management of implanted device

162

388

4.23

61.05

1.3

1.2

37.14

25.09

u/l

1.70

145

318

Complications of surgical and medical care, not elsewhere classified

623

1975

2.11

60.91

1.3

1.2

31.20

24.82

u/l

1.45

539

1663

Gout, FINNGEN

219

649

3.39

59.88

1.3

37.77

30.13

u/l

0.89

188

524

Disorders of lipoprotein metabolism and other lipidaemias

522

1403

2.27

59.47

1.2

25.76

26.23

u/l

0.06

438

1177

Insulin, fast-acting (human)

125

249

5.09

59.13

1.4

1.1

37.91

23.41

u/l

1.45

115

202

Sub-endpoint used in defining T1D endpoints

218

647

3.35

58.40

1.3

1.2

33.30

26.59

u/l

0.86

200

526

Other disorders of skin and subcutaneous tissue

493

1873

2.23

58.24

1.3

1.2

27.74

26.13

u/l

0.27

415

1583

Implicit viral Sepsis

178

475

3.79

57.77

1.3

1.2

39.45

23.94

u/l

2.09

155

380

Viral Sepsis

178

475

3.79

57.77

1.3

1.2

39.45

23.94

u/l

2.09

155

380

Diarrhoea and gastroenteritis of presumed infectious origin

447

1741

2.30

57.51

1.3

1.2

27.75

23.95

u/l

0.79

384

1453

Persons encountering health services for other counselling and medical advice, not elsewhere classified

662

1712

2.06

57.41

1.3

1.2

26.09

26.41

u/l

0.04

576

1431

Other inflammatory liver diseases

124

7.13

56.86

1.3

1.1

31.51

15.37

u/l

1.31

100

Opioids

534

1233

2.25

56.57

1.3

1.2

27.49

20.81

u/l

1.31

447

1047

Colitis, primary sclerosing

21.11

56.01

1.3

1.4

48.79

17.06

u/l

0.94

Intestinal infectious diseases, including avohilmo, including avohilmo

680

1891

2.01

55.80

1.3

1.2

29.43

24.75

u/l

1.00

587

1591

Gastrointestinal diseases

283

456

3.12

55.40

1.2

27.58

18.54

u/l

1.06

243

379

Gout

219

577

3.29

55.09

1.3

37.77

30.72

u/l

0.77

188

472

Persons encountering health services for specific procedures, not carried out

138

6.57

54.87

1.3

1.2

35.96

17.74

u/l

1.45

108

Other disorders of fluid, electrolyte and acid-base balance

241

752

3.05

54.68

1.3

35.67

25.12

u/l

1.26

212

619

Pain in limb

504

1456

2.21

54.43

1.2

1.3

28.56

25.36

u/l

0.53

421

1231

Crohn's disease of large intestine

8.24

53.92

1.4

1.2

22.82

17.19

u/l

0.50

Personal history of malignant neoplasm

112

223

5.14

53.22

1.2

24.67

19.35

u/l

0.24

187

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

130

6.70

53.19

1.3

1.2

19.25

16.66

u/l

0.25

110

Malignant neoplasm

493

1304

2.22

52.97

1.3

1.2

30.76

22.42

u/l

1.35

418

1097

Malignant neoplasm of breast, HER-positive

271

710

2.87

52.13

1.2

20.59

20.36

u/l

0.02

239

597

Malignant neoplasm of breast, HER2-negative

322

785

2.67

52.05

1.2

21.26

20.88

u/l

0.03

274

664

Malignant neoplasm of breast

322

785

2.67

52.02

1.2

21.26

20.88

u/l

0.03

274

664

Malignant neoplasm

491

1307

2.21

51.99

1.3

1.2

30.69

22.39

u/l

1.34

416

1100

Covid-19 confirmed case

270

985

2.76

51.98

1.3

1.2

31.76

25.84

u/l

1.10

237

809

Malignant neoplasm of breast, ER-positive, including Hilmo

271

711

2.86

51.86

1.2

20.59

20.35

u/l

0.02

239

598

Codeine

498

1220

2.21

51.84

1.2

25.26

20.99

u/l

0.80

412

1034

Crohn disease (strict definition, require KELA, min 2 HDR)

118

6.95

51.80

1.3

1.2

19.55

17.39

u/l

0.19

100

Unspecified privation

108

214

5.14

51.52

1.2

35.03

20.72

u/l

1.32

176

Peripheral artery disease

301

899

2.67

51.30

1.3

35.83

27.93

u/l

1.34

266

735

Malignant neoplasm of breast, HER2-negative, including Hilmo

323

790

2.64

51.12

1.2

21.48

21.02

u/l

0.04

275

669

Amputation

106

208

5.19

51.11

1.4

1.3

40.56

26.27

u/l

1.66

101

171

Malignant neoplasm of breast, including Hilmo

323

790

2.64

51.10

1.2

21.48

21.02

u/l

0.04

275

669

Crohn disease (strict definition, require KELA)

120

6.83

50.99

1.3

1.2

19.55

17.15

u/l

0.21

102

Hypertensive diseases

436

1068

2.31

50.74

1.3

23.09

24.82

u/l

0.26

363

910

Hypertension

436

1068

2.31

50.72

1.3

23.09

24.82

u/l

0.26

363

910

Asthma, unspecified (mode), excluding more controls

307

836

2.64

50.28

1.3

1.2

32.75

17.29

u/l

2.56

256

699

Oedema, not elsewhere classified

237

803

2.91

50.01

1.3

1.2

32.79

21.59

u/l

1.49

197

653

Gout, idiopatic and unspecified

188

576

3.30

49.48

1.3

37.76

27.90

u/l

1.14

164

462

Crohn's disease of small intestine

122

6.62

48.97

1.6

1.2

20.87

16.28

u/l

0.46

102

Gout, strict definition

151

404

3.79

48.95

1.2

1.3

33.20

27.27

u/l

0.65

133

322

Osteoporosis

239

770

2.88

48.88

1.3

1.2

26.49

25.75

u/l

0.07

200

644

Chronic hepatitis, not elsewhere classified

9.87

48.88

1.4

1.1

20.45

15.98

u/l

0.73

Complications of procedures, not elsewhere classified

494

1925

2.08

48.25

1.3

1.2

29.85

25.03

u/l

0.95

426

1618

Malignant neoplasm, including Hilmo

484

1315

2.15

48.08

1.3

1.2

27.83

22.45

u/l

0.81

410

1107

Hypertension, essential

422

1047

2.29

48.03

1.3

23.03

25.13

u/l

0.32

349

891

Heart failure and bmi 25plus

239

542

2.97

47.27

1.2

37.51

23.78

u/l

2.78

205

456

Other arthritis (FG)

228

802

2.87

47.23

1.2

1.3

26.71

22.38

u/l

0.56

197

661

Certain disorders involving the immune mechanism

165

481

3.48

47.07

1.3

1.2

30.39

25.12

u/l

0.35

147

394

Codes for special purposes

344

1468

2.34

46.81

1.3

1.2

30.23

24.13

u/l

1.35

304

1224

Malignant neoplasm, wide definition

482

1321

2.13

46.80

1.3

1.2

27.95

22.38

u/l

0.84

407

1113

Endocrine, nutritional and metabolic diseases

390

832

2.38

46.63

1.2

23.96

22.66

u/l

0.13

335

685

Pure hypercholesterolaemia

453

1336

2.16

46.56

1.2

26.72

25.77

u/l

0.13

384

1117

Cardiovascular diseases (excluding rheumatic etc)

317

709

2.57

46.22

1.3

1.2

21.83

20.58

u/l

0.14

279

606

Peripheral artery operations in Hilmo

114

259

4.46

46.09

1.4

1.2

39.78

26.16

u/l

1.63

107

211

Provisional assignment of new diseases of uncertain etiology

342

1468

2.32

45.94

1.3

1.2

30.25

24.15

u/l

1.34

302

1224

Solid cancers

466

1281

2.14

45.83

1.3

1.2

27.45

22.17

u/l

0.79

389

1079

Biological medication for rheuma

150

419

3.62

45.66

1.2

18.55

23.69

u/l

0.63

131

350

Other heart diseases, wide

506

1495

2.06

45.22

1.3

1.2

25.15

23.29

u/l

0.36

440

1260

Gout, unspecified

159

467

3.45

44.83

1.3

35.06

27.89

u/l

0.75

139

366

Persons encountering health services in other circumstances, wide

637

1716

1.91

44.82

1.3

1.2

25.66

26.39

u/l

0.11

545

1435

Care involving use of rehabilitation procedures

378

1539

2.22

44.75

1.3

1.2

25.82

22.67

u/l

0.43

330

1274

Complications of medical and surgical care

458

2010

2.06

44.61

1.3

1.2

35.06

24.61

u/l

2.19

395

1696

Atherosclerosis, excluding cerebral and coronary sclerosis

273

838

2.58

43.63

1.3

33.47

27.38

u/l

0.98

240

687

Other specified/unspecified arthritis

204

708

2.91

43.38

1.2

1.3

23.51

24.41

u/l

0.10

176

586

Asthma, unspecified (mode)

314

940

2.42

43.31

1.3

1.2

32.38

19.36

u/l

2.00

260

787

Ulcerative ileocolitis

8.97

43.30

1.2

42.06

17.23

u/l

0.96

Other diseases of intestine

137

374

3.71

43.19

1.4

1.3

33.40

23.56

u/l

0.76

113

308

Solid cancers, including Hilmo

467

1309

2.09

43.02

1.3

1.2

28.33

22.43

u/l

0.92

390

1103

Finngen Rheumatological endpoints

513

1449

2.02

42.89

1.2

1.3

23.69

25.97

u/l

0.35

437

1229

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

571

1917

1.92

42.61

1.3

1.2

27.83

24.87

u/l

0.48

493

1611

Other noninfective gastroenteritis and colitis

185

614

3.04

42.55

1.3

1.2

24.83

24.82

u/l

0.00

155

501

Bleeding

498

1759

1.99

42.39

1.3

1.2

30.40

25.35

u/l

1.12

435

1466

Hypertensive heart and/or renal disease

175

392

3.29

42.19

1.3

33.55

25.91

u/l

1.12

155

323

Follow-up examination after treatment for conditions other than malignant neoplasms

264

672

2.63

42.18

1.3

1.2

22.95

24.39

u/l

0.14

223

560

Pain, not elsewhere classified

192

659

2.94

41.65

1.4

1.2

33.38

20.06

u/l

1.83

173

537

Hypertensive Renal Disease

9.34

41.41

1.3

1.4

36.75

25.48

u/l

0.60

Other diseases of biliary tract

196

4.84

41.38

1.4

1.2

47.65

19.73

u/l

1.53

157

Osteomyelitis

117

6.20

41.35

1.5

1.2

33.71

21.73

u/l

1.07

Diseases of the digestive system

304

1302

2.33

41.25

1.3

1.2

33.51

25.78

u/l

1.29

272

1077

Tumor necrosis factor alpha inhibitors

135

378

3.62

41.01

1.1

1.2

17.56

24.28

u/l

0.84

117

315

Other and unspecified polyneuropathies, also in other diseases

152

460

3.34

40.94

1.3

1.2

28.72

24.36

u/l

0.47

127

366

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

386

1808

2.10

40.63

1.3

1.2

29.24

24.34

u/l

0.90

332

1515

Infections of the skin and subcutaneous tissue

350

1584

2.18

40.62

1.3

1.2

31.83

24.61

u/l

1.17

313

1310

Hernia of abdominal wall, postoperative

113

279

4.06

40.49

1.3

1.2

37.99

17.48

u/l

1.78

223

Diabetes, varying definitions

560

1705

1.91

40.48

1.3

1.2

25.87

24.15

u/l

0.32

488

1422

Pain in joint

329

868

2.34

40.38

1.2

23.45

26.56

u/l

0.32

281

730

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

419

1786

2.05

40.33

1.2

30.62

25.60

u/l

0.91

352

1497

Chronic gastritis

202

729

2.80

40.00

1.2

33.67

26.82

u/l

0.57

171

595

Any event in cancer register

480

1403

2.01

39.86

1.3

1.2

28.83

22.73

u/l

0.95

404

1184

Oesophageal varices

7.12

39.58

1.2

39.95

17.39

u/l

1.85

Sulfasalazine

189

663

2.87

39.44

1.3

1.2

22.23

21.67

u/l

0.05

169

553

Asthma, excluding more controls

373

859

2.24

39.39

1.3

1.2

33.59

17.01

u/l

2.93

307

719

Heart failure and coronary heart disease

285

827

2.43

39.25

1.2

1.3

40.65

28.09

u/l

2.46

248

676

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

531

1647

1.92

39.14

1.3

28.66

24.57

u/l

0.87

462

1371

Medical observation and evaluation for suspected diseases and conditions

339

748

2.33

39.00

1.3

1.2

21.82

25.49

u/l

0.77

291

627

Cholelithiasis, broad definition with cholecystitis

490

1683

1.95

38.55

1.3

1.2

31.24

23.49

u/l

1.66

417

1405

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

241

576

2.65

38.53

1.3

1.2

27.62

22.51

u/l

0.63

206

488

Glomerulonephritis

192

4.71

38.50

1.4

1.2

24.77

21.37

u/l

0.31

158

Polyneuropathies and other disorders of the peripheral nervous system

165

545

3.06

38.42

1.3

1.2

29.43

25.04

u/l

0.47

139

435

Continuous positive airway pressure

132

306

3.63

38.42

1.2

1.3

40.11

22.16

u/l

1.85

116

252

Diabetes mellitus

555

1708

1.88

38.40

1.3

25.94

24.14

u/l

0.34

483

1425

L02BG Aromatase inhibitors

247

993

2.48

38.31

1.2

18.77

24.30

u/l

0.66

219

822

Hyperkalaemia

6.69

38.31

1.5

1.3

38.16

21.41

u/l

1.43

Other soft tissue disorders, not elsewhere classified

503

1483

1.94

37.64

1.2

1.3

28.39

25.29

u/l

0.51

420

1258

Cardiovascular diseases

276

589

2.50

37.31

1.3

1.2

19.97

19.06

u/l

0.10

238

500

Other retinal disorders

397

1480

2.05

37.09

1.3

1.2

30.60

27.15

u/l

0.52

334

1251

Cholelithiasis

472

1670

1.94

36.90

1.2

30.77

23.36

u/l

1.53

401

1393

Asthma

396

967

2.12

36.83

1.3

1.2

33.80

19.15

u/l

2.60

327

810

Certain infectious and parasitic diseases, including avohilmo

348

780

2.24

36.76

1.2

30.52

18.18

u/l

2.04

293

639

Streptococcal septicaemia, including avohilmo

153

5.11

36.69

1.5

1.2

29.17

17.74

u/l

1.33

125

Codeine or tramadol medication

600

1800

1.82

36.61

1.2

1.3

25.45

26.30

u/l

0.12

495

1538

Bacterial pneumonia, not elsewhere classified

240

854

2.48

36.59

1.3

1.2

37.31

24.76

u/l

1.71

212

703

COPD/asthma/ILD related infections

537

1424

1.90

36.58

1.3

1.2

25.72

21.16

u/l

1.01

462

1190

COPD/asthma related infections

537

1424

1.90

36.58

1.3

1.2

25.72

21.16

u/l

1.01

462

1190

Low back pain

433

1476

1.99

36.40

1.3

28.22

25.78

u/l

0.35

376

1253

Medicines for HER+ breast cancer

276

1120

2.31

36.34

1.2

20.58

23.73

u/l

0.30

243

936

Other diseases of arteries and capillaries

198

4.52

36.18

1.4

1.2

34.82

20.04

u/l

1.03

163

Liquid cancers

190

659

2.75

36.11

1.2

43.24

22.90

u/l

2.51

171

542

Bacterial pneumoniae

249

908

2.42

35.99

1.3

1.2

36.25

24.29

u/l

1.69

221

754

Asthma (only as main-diagnosis), excluding more controls

342

859

2.21

35.89

1.3

1.2

30.90

17.01

u/l

2.36

296

719

Explicit bacterial Sepsis, including avohilmo

195

4.52

35.87

1.4

1.2

27.25

18.55

u/l

1.04

163

Atrial fibrillation and flutter

189

424

2.90

35.75

1.3

1.2

28.67

21.42

u/l

0.89

165

356

Disorders of choroid and retina

479

1770

1.90

35.72

1.3

1.2

28.35

26.75

u/l

0.24

399

1504

Rheumatoid arthritis

223

785

2.53

35.51

1.2

22.60

24.50

u/l

0.29

198

654

Diabetes, insulin treatment (Kela reimbursement)

562

1841

1.82

35.47

1.3

29.38

24.80

u/l

1.06

491

1538

Acute peritonitis

122

5.61

35.23

1.4

1.2

28.81

20.88

u/l

0.69

100

Diaphragmatic hernia

256

1104

2.34

35.01

1.2

1.3

27.42

25.52

u/l

0.19

210

914

Cardiac arrhythmias

313

905

2.23

34.80

1.3

1.2

24.61

22.29

u/l

0.32

270

756

Ulcerative rectosigmoiditis

138

5.23

34.71

1.5

1.1

27.62

17.75

u/l

0.43

108

Hypothyroidism (congenital or acquired)

100

121

4.65

34.54

1.3

1.2

26.60

12.49

u/l

1.28

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

7.63

34.49

1.4

1.2

36.07

13.20

u/l

1.97

Streptococcal septicaemia

150

5.01

34.48

1.5

1.2

29.69

17.54

u/l

1.37

123

Disorders of mineral metabolism

166

4.78

34.34

1.4

1.3

31.68

22.99

u/l

0.60

135

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

351

1730

2.03

33.97

1.4

1.2

30.19

25.41

u/l

0.75

300

1443

Liquid cancers, including Hilmo

218

773

2.50

33.85

1.2

42.63

23.15

u/l

2.67

195

640

Explicit bacterial Sepsis

193

4.41

33.59

1.5

1.2

27.63

18.40

u/l

1.08

161

Spondyloarthritis

119

351

3.42

33.42

1.2

36.24

24.04

u/l

0.99

107

281

Neoplasms

335

811

2.17

33.40

1.2

26.38

20.97

u/l

0.63

282

692

Congenital malformations of the urinary system

111

5.71

33.21

1.4

1.2

25.58

16.78

u/l

1.05

Asthma (mode)

381

975

2.06

33.20

1.3

1.2

34.50

19.20

u/l

2.69

314

817

Diabetes medication

557

1822

1.79

33.14

1.3

1.2

27.55

24.04

u/l

0.79

484

1527

Haemorrhage from respiratory passages

223

812

2.45

33.05

1.3

1.2

34.74

25.42

u/l

1.43

194

673

Diverticular disease of intestine

405

1281

1.98

32.94

1.2

24.79

25.01

u/l

0.03

340

1077

Non-ischemic cardiomyopathy

207

646

2.56

32.88

1.2

1.3

27.68

25.73

u/l

0.23

176

532

Cutaneous abscess, furuncle and carbuncle

174

646

2.72

32.73

1.3

1.2

28.13

21.33

u/l

1.00

159

536

Type 2 diabetes, wide definition

452

1509

1.90

32.71

1.3

29.00

25.08

u/l

0.69

394

1253

Hypothyroidism, levothyroxine purchases

121

4.51

32.48

1.3

1.2

26.17

12.49

u/l

1.20

Hypothyroidism and >3 levothyroxin purchases

121

4.51

32.48

1.3

1.2

26.17

12.49

u/l

1.20

Congenital malformations of the urinary system, including avohilmo

118

5.45

32.15

1.3

1.2

25.47

16.55

u/l

1.11

101

Adalimumab

200

4.26

32.13

1.1

1.2

17.81

25.15

u/l

0.62

163

Crohn disease (strict definition, all UC cases excluded)

6.09

32.07

1.3

1.2

14.52

17.95

u/l

0.35

Constipation

502

1884

1.81

32.03

1.3

1.2

28.06

26.01

u/l

0.27

423

1598

Cardiomyopathy

116

346

3.38

32.01

1.2

1.3

35.00

22.86

u/l

2.09

100

276

Oxycodone

236

862

2.35

31.94

1.5

1.2

47.30

22.67

u/l

4.00

212

717

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

5.05

31.87

1.2

1.4

47.62

20.54

u/l

1.08

Alcoholic liver disease

185

4.39

31.79

1.3

1.2

53.04

22.89

u/l

2.21

149

Systemic connective tissue disorders

240

1051

2.30

31.73

1.3

1.2

28.62

23.65

u/l

0.66

205

873

104

293

3.59

31.40

1.3

1.2

23.32

23.44

u/l

0.01

236

Other diseases of blood and blood-forming organs, wide

164

604

2.74

31.40

1.2

30.46

25.05

u/l

0.54

152

493

Nausea and vomiting

183

695

2.59

31.12

1.3

1.2

29.78

23.77

u/l

0.70

157

571

Amputation of foot

8.34

30.91

1.4

1.3

43.78

27.24

u/l

0.97

Asthma (only as main-diagnosis)

353

967

2.05

30.86

1.3

1.2

31.62

19.15

u/l

2.04

306

810

Fall on same level

578

1772

1.74

30.82

1.3

1.2

27.10

24.46

u/l

0.48

484

1516

Bacterial pneumonia (organism specified)

267

1111

2.19

30.77

1.3

1.2

35.56

25.39

u/l

1.46

236

920

Pain in throat and chest

432

1361

1.88

30.35

1.2

25.08

24.21

u/l

0.12

359

1146

Viral pneumonia

258

3.72

30.30

1.4

1.2

32.13

20.27

u/l

1.54

213

GI-bleeding

204

851

2.41

30.13

1.2

33.85

28.69

u/l

0.55

181

685

Disorders of thyroid, IBD co-morbidities

169

3.95

29.99

1.2

1.3

22.44

24.97

u/l

0.15

142

Benign neoplasm of colon, rectum, anus and anal canal

381

1694

1.91

29.97

1.2

35.84

25.55

u/l

1.35

315

1420

Polycystic kidney disease

8.02

29.95

1.3

1.2

28.62

16.35

u/l

1.57

Diseases of the skin and subcutaneous tissue

479

1315

1.83

29.67

1.3

1.2

26.39

24.80

u/l

0.19

403

1108

Diabetic retinopathy, excluding more controls

187

394

2.68

29.47

1.4

1.2

30.84

28.11

u/l

0.24

163

334

Disorder of lipoprotein metabolism, unspecified

268

3.62

29.43

1.4

1.3

30.75

26.63

u/l

0.24

215

Other CVD (FINNGEN)

143

4.37

29.40

1.5

1.3

23.21

27.43

u/l

0.21

117

Type 2 diabetes

507

1657

1.78

29.40

1.2

1.3

25.51

24.50

u/l

0.16

437

1379

Asthma, hospital admission 2, infections

340

1704

1.95

29.35

1.3

1.2

38.18

23.71

u/l

2.21

288

1445

Asthma-related infections

340

1704

1.95

29.35

1.3

1.2

38.18

23.71

u/l

2.21

288

1445

Gastro-oesophageal reflux disease

371

1644

1.91

29.25

1.3

1.2

26.15

25.93

u/l

0.02

311

1391

Other ulcerative colitis

100

5.60

28.99

1.5

1.2

38.26

17.38

u/l

0.75

6-mercaptopurine

8.96

28.99

1.5

1.2

19.55

13.78

u/l

0.50

Fracture of femur

183

662

2.51

28.80

1.3

1.2

28.90

27.37

u/l

0.13

159

538

Other specific joint derangements/joint disorders

371

1197

1.94

28.67

1.3

25.83

25.99

u/l

0.01

315

1006

Pleural effusion

114

361

3.19

28.67

1.2

49.35

25.75

u/l

1.79

293

Noninfectious colitis NAS

288

3.47

28.52

1.3

1.2

25.09

21.31

u/l

0.32

231

Other gastritis (incl. Duodenitis)

150

555

2.73

28.50

1.3

1.2

33.82

25.57

u/l

0.51

127

450

Atrial fibrillation and flutter with reimbursement

153

341

2.85

28.03

1.2

25.61

22.79

u/l

0.28

132

287

Asthma-related pneumonia or sepsis

235

1073

2.20

27.88

1.3

1.2

44.35

25.50

u/l

2.06

198

894

Asthma, hospital admissions 3, pneumonia

235

1073

2.20

27.88

1.3

1.2

44.35

25.50

u/l

2.06

198

894

Other diseases of pancreas

179

4.20

27.80

1.4

1.3

38.52

21.07

u/l

1.09

151

Other diseases of urinary system

500

1602

1.76

27.78

1.3

1.2

27.13

25.39

u/l

0.23

413

1365

Other diseases of the digestive system

199

853

2.35

27.71

1.2

33.69

28.71

u/l

0.51

178

685

Asthma-related pneumonia

234

1070

2.19

27.67

1.3

1.2

44.39

25.55

u/l

2.05

197

892

Abnormal results of function studies

184

4.13

27.64

1.3

1.1

23.45

19.22

u/l

0.49

151

Lower back pain or/and sciatica

558

2059

1.69

27.58

1.3

1.2

28.36

25.30

u/l

0.57

476

1742

Cystic kidney disease

6.41

27.57

1.3

1.2

26.68

20.35

u/l

0.64

COPD differential diagnosis

376

975

1.94

27.56

1.3

1.2

26.52

19.20

u/l

1.42

322

817

ILD differential diagnosis

376

975

1.94

27.55

1.3

1.2

26.52

19.20

u/l

1.42

322

817

Excluding asthma or asthma-COPD overlap

377

979

1.94

27.51

1.3

1.2

26.48

19.00

u/l

1.46

322

822

Other disorders of urethra and urinary system

380

1416

1.87

27.25

1.2

25.08

24.73

u/l

0.04

316

1196

Cystic kidney disease, including avohilmo

6.31

27.20

1.3

1.2

26.68

20.33

u/l

0.65

Paralytic ileus and intestinal obstruction

163

643

2.55

27.18

1.4

1.2

45.94

24.47

u/l

1.95

145

524

Abnormalities of breathing

434

1372

1.81

26.97

1.3

1.2

31.46

24.04

u/l

1.51

366

1155

Seropositive rheumatoid arthritis

168

672

2.51

26.93

1.2

22.83

22.25

u/l

0.07

150

557

Artificial opening status

100

5.40

26.87

1.4

1.2

56.33

19.45

u/l

1.70

UC patients in KELA-register (code 208), prior to 1994

5.84

26.87

1.5

1.2

14.98

20.06

u/l

0.63

Chronic pancreatitis

271

3.47

26.77

1.4

1.2

48.14

22.47

u/l

1.45

221

Other pulmonary diagnosis

374

979

1.92

26.69

1.3

1.2

26.54

19.00

u/l

1.46

318

822

Benign neoplasm: Colon

325

1595

1.92

26.59

1.2

35.81

26.15

u/l

1.05

269

1331

Other bacterial intestinal infections

125

437

2.89

26.47

1.4

1.2

36.10

26.82

u/l

0.87

110

358

Hypothyroidism, drug reimbursement

4.83

26.17

1.2

31.30

11.57

u/l

1.50

Other systemic involvement of connective tissue (FG)

168

672

2.47

26.13

1.3

1.2

28.63

23.58

u/l

0.47

144

559

Collagenous colitis

197

3.91

26.00

1.3

1.2

27.38

21.00

u/l

0.55

160

Antihypertensive medication - note that there are other indications

256

614

2.19

25.99

1.2

1.3

23.63

19.71

u/l

0.39

221

520

Rheumatoid arthritis, including avohilmo

241

1154

2.10

25.63

1.2

22.09

24.75

u/l

0.49

211

954

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

156

4.30

25.58

1.4

1.2

26.58

19.42

u/l

0.86

125

Asthma (diagnoses ohter than nonallergic)

460

2167

1.72

25.58

1.3

1.2

30.82

24.87

u/l

0.95

380

1848

Cardiomyopathy, other and unspecified

136

4.55

25.45

1.2

33.98

23.69

u/l

0.88

109

Dyspnoea

475

2016

1.71

25.13

1.3

30.77

25.73

u/l

1.09

405

1701

Cystitis

435

1467

1.77

25.13

1.2

26.92

24.44

u/l

0.31

363

1242

Immunodeficiencies

5.57

25.13

1.3

1.2

23.58

16.77

u/l

0.98

Disorders of lens

380

1287

1.84

25.10

1.3

1.2

29.45

23.73

u/l

1.12

334

1078

Statin medication

323

934

1.95

25.02

1.2

1.3

29.10

25.00

u/l

0.38

273

811

Cerebrovascular diseases (FINNGEN)

163

453

2.53

24.83

1.3

1.2

28.37

22.79

u/l

0.54

138

383

Cholecystectomy

398

1914

1.77

24.82

1.3

1.2

27.05

26.03

u/l

0.12

342

1604

Diseases of peritoneum

227

3.62

24.78

1.3

1.2

27.62

22.54

u/l

0.42

185

Fungal Sepsis

5.82

24.66

1.6

1.2

68.03

14.86

u/l

3.00

Spondylopathies

412

1368

1.79

24.58

1.2

26.51

27.39

u/l

0.11

344

1157

Depression

493

1964

1.68

24.50

1.2

1.3

25.97

24.57

u/l

0.20

423

1653

Speech therapy

175

751

2.35

24.42

1.2

26.49

25.12

u/l

0.09

146

613

Type 1 diabetes, definitions combined

145

4.31

24.22

1.4

1.2

37.42

21.69

u/l

0.91

122

Viral and other specified intestinal infections

107

351

2.99

24.17

1.3

1.2

45.32

19.74

u/l

1.75

100

293

All influenza

151

610

2.49

24.04

1.4

1.2

30.50

23.83

u/l

0.72

135

492

Valvular heart disease excluding rheumatic fever

249

862

2.07

23.96

1.3

1.2

29.80

23.98

u/l

0.85

210

708

Non-rheumatic valve diseases

248

858

2.07

23.86

1.3

1.2

29.91

23.90

u/l

0.89

209

704

L04AC Interleukin inhibitors

123

4.62

23.83

1.1

22.69

20.30

u/l

0.15

100

Nephrotic syndrome

6.47

23.64

1.3

1.2

24.00

20.25

u/l

0.23

Osteonecrosis

133

4.44

23.42

1.4

1.2

29.62

21.03

u/l

0.69

111

Bacterial intestinal infections, IBD co-morbidities

125

467

2.70

23.41

1.4

1.2

36.21

27.64

u/l

0.80

110

379

Type 1 diabetes, strict (exclude DM2)

149

4.19

23.39

1.4

1.2

37.42

21.80

u/l

0.91

126

Hypertensive Heart Disease

131

368

2.72

23.33

1.2

1.3

34.13

25.16

u/l

1.42

116

305

Other nutritional deficiencies

354

1812

1.79

23.19

1.3

21.93

24.61

u/l

0.58

299

1528

Mood disorders

519

2032

1.64

23.06

1.2

1.3

26.56

25.07

u/l

0.22

445

1712

Other bacterial intestinal infections, including avohilmo

147

599

2.47

23.03

1.3

1.2

36.44

25.87

u/l

1.20

125

489

Mood disorders, excluding more controls

474

1660

1.68

22.97

1.2

1.3

27.26

25.37

u/l

0.27

405

1415

Other functional intestinal disorders

248

1130

2.00

22.86

1.3

1.2

31.78

23.11

u/l

1.35

214

947

Other or unspecified ileus, impaction or obstruction

115

417

2.78

22.79

1.5

1.2

53.94

26.44

u/l

1.72

101

332

Mood [affective] disorders

517

2033

1.63

22.75

1.2

1.3

26.42

25.06

u/l

0.20

443

1713

Fracture of lumbar spine and pelvis

146

595

2.47

22.74

1.3

1.2

33.02

26.21

u/l

0.49

130

476

Peripheral arterial reconstruction

110

391

2.84

22.67

1.3

30.80

29.45

u/l

0.11

318

Use of hypnotics and sedatives

527

1851

1.63

22.56

1.3

1.2

28.66

25.77

u/l

0.47

444

1570

Viral and other specified intestinal infections, including avohilmo

142

551

2.49

22.54

1.3

1.2

40.84

21.55

u/l

1.58

130

462

Dorsalgia

477

1507

1.68

22.53

1.2

1.3

24.22

26.06

u/l

0.31

400

1283

Other diseases of pleura

251

1104

1.98

22.39

1.3

1.2

47.72

26.77

u/l

3.33

215

912

Anxiety disorders, excluding more controls

421

1572

1.72

22.32

1.2

1.3

23.99

24.59

u/l

0.07

354

1333

Primary_lymphoid and hematopoietic malignant neoplasms

150

628

2.41

22.18

1.2

48.60

27.11

u/l

1.86

135

505

Vitreous haemorrhage

225

3.46

22.15

1.5

1.2

27.68

21.93

u/l

0.62

183

Hyperlipidaemia, other/unspecified

213

919

2.09

22.12

1.3

28.51

25.92

u/l

0.24

181

764

Viral pneumonia (unknown virus, not influenza)

123

4.45

21.98

1.3

1.2

41.80

19.44

u/l

2.10

106

Gingivitis and periodontal diseases

487

1517

1.66

21.93

1.3

1.2

26.97

27.64

u/l

0.07

408

1275

Implicit fungal Sepsis

5.66

21.85

1.6

1.2

62.49

14.97

u/l

2.46

Cellulitis

137

554

2.49

21.85

1.4

1.2

31.85

22.61

u/l

1.20

127

455

Hypokalaemia

277

3.17

21.80

1.3

1.2

25.73

27.60

u/l

0.13

222

Arthropathies in other diseases classified elsewhere

6.61

21.79

1.3

1.2

37.52

15.09

u/l

1.69

Injuries to the abdomen, lower back, lumbar spine and pelvis

234

1160

2.00

21.76

1.3

1.2

28.54

25.05

u/l

0.35

204

952

Benign neoplasm of other and ill-defined parts of digestive system

126

492

2.59

21.66

1.3

1.2

30.44

25.80

u/l

0.27

113

401

Implicit fungal Sepsis, including avohilmo

137

4.22

21.66

1.5

1.2

53.69

14.93

u/l

2.80

114

244

1239

1.96

21.60

1.4

1.2

37.51

21.85

u/l

1.85

213

1039

Gingival hyperplasia

5.59

21.56

1.4

1.2

28.18

18.03

u/l

0.73

Urinary track infection

318

853

1.87

21.27

1.3

1.2

23.22

21.67

u/l

0.16

268

730

Anxiety (asthma-related co-morbidities)

307

1274

1.84

21.27

1.2

1.3

21.98

23.75

u/l

0.21

258

1069

Cardiomyopathy (excluding other)

231

3.36

21.25

1.2

40.05

20.91

u/l

3.06

183

Idiopathic gout

179

3.73

21.24

1.3

47.87

25.07

u/l

1.44

147

Presence of cardiac and vascular implants and grafts

234

858

2.01

21.11

1.3

36.25

27.93

u/l

1.23

202

702

Paroxysmal tachycardia

115

354

2.71

20.99

1.5

1.2

28.46

24.49

u/l

0.26

104

299

L02BA Anti-estrogens

127

506

2.54

20.97

1.2

24.13

21.18

u/l

0.14

114

415

Injuries to the hip and thigh

274

1314

1.88

20.90

1.3

1.2

28.69

26.95

u/l

0.20

235

1095

Enterocolitis due to Clostridium difficile

234

3.33

20.84

1.4

1.2

39.20

25.01

u/l

1.27

191

Intestinal stricture

188

888

2.13

20.84

1.4

1.2

42.80

25.74

u/l

1.62

163

717

ILD, hospital admission 2, with pulmonary infections

191

3.60

20.78

1.1

1.3

58.17

23.73

u/l

1.39

153

Other systemic involvement of connective tissue

175

805

2.19

20.77

1.3

1.2

28.40

24.50

u/l

0.35

151

666

Diabetic retinopathy, strict definition

122

420

2.61

20.76

1.4

1.2

31.50

29.51

u/l

0.17

113

360

Gastroduodenal ulcer

148

633

2.35

20.71

1.3

29.84

28.91

u/l

0.07

126

512

Methotrexate

312

2.98

20.70

1.2

24.95

22.92

u/l

0.15

258

Other diseases of stomach and duodenum

138

4.12

20.62

1.3

1.2

48.84

19.39

u/l

1.02

113

Abdominal and pelvic pain

458

1386

1.66

20.59

1.2

25.89

24.74

u/l

0.15

385

1161

Symptoms and signs involving cognition, perception, emotional state and behaviour

484

2010

1.61

20.52

1.2

1.3

25.25

26.88

u/l

0.25

404

1710

Dermatitis and eczema

554

2094

1.57

20.48

1.3

1.2

29.40

25.30

u/l

0.58

472

1777

Symptoms and signs involving the digestive system and abdomen

458

1386

1.66

20.43

1.3

1.2

26.72

24.74

u/l

0.27

385

1161

Hypo-osmolality and hyponatraemia

110

410

2.68

20.40

1.2

41.95

26.57

u/l

0.88

328

Total colectomy

5.29

20.37

1.7

1.2

28.19

18.74

u/l

0.44

Total colectomy operation

5.29

20.37

1.7

1.2

28.19

18.74

u/l

0.44

Ulcerative proctitis

102

4.67

20.32

1.6

1.2

14.20

17.56

u/l

0.42

Diabetic maculopathy, excluding more controls

200

3.48

20.12

1.4

1.2

32.26

23.33

u/l

0.60

163

Other necrotizing vasculopathies

154

3.89

20.09

1.4

1.2

26.59

19.84

u/l

0.77

127

Neurotic, stress-related and somatoform disorders

447

1892

1.63

19.98

1.2

1.3

23.31

24.73

u/l

0.21

378

1600

Periodontitis

501

2012

1.59

19.90

1.3

1.2

24.97

26.07

u/l

0.15

422

1701

Anxiety disorders

451

1907

1.63

19.90

1.2

1.3

23.18

24.78

u/l

0.25

382

1613

Hypothyroidism, strict autoimmune

298

1073

1.83

19.75

1.2

26.41

26.58

u/l

0.01

253

872

Cardiomyopathies, Primary/intrinsic

222

3.32

19.75

1.2

1.3

40.95

21.22

u/l

3.04

178

Symptoms and signs involving the circulatory and respiratory systems

452

1377

1.65

19.68

1.3

1.2

25.11

23.97

u/l

0.17

386

1160

Coagulation defects, purpura and other haemorrhagic conditions

122

492

2.50

19.63

1.3

1.2

26.46

26.57

u/l

0.01

117

408

Vascular disorders of the intestines

130

4.13

19.62

1.4

1.3

22.06

23.94

u/l

0.18

105

Primary hyperparathyroidism

312

2.92

19.54

1.2

13.14

23.89

u/l

1.91

257

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

139

275

2.54

19.49

1.2

24.22

17.70

u/l

0.44

118

223

Chronic periodontitis, including avohilmo

499

2015

1.58

19.49

1.3

1.2

25.73

26.09

u/l

0.04

420

1704

Open wound of lower leg

362

2.76

19.42

1.4

1.2

29.02

25.43

u/l

0.29

301

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

110

4.42

19.42

1.1

1.2

50.26

20.77

u/l

1.90

Psoriatic and enteropathic arthropathies

250

3.15

19.38

1.2

15.23

20.97

u/l

0.98

201

Chronic nephritic syndrome

5.39

19.25

1.4

1.2

16.39

20.52

u/l

0.50

Chronic tubulo-interstitial nephritis

5.38

19.24

1.3

1.2

17.83

18.03

u/l

0.02

Depression medications

129

3.36

19.21

1.2

28.58

11.97

u/l

1.00

106

All anxiety disorders

310

1364

1.77

19.10

1.2

1.3

21.79

23.64

u/l

0.22

261

1147

Headache

296

1279

1.79

19.07

1.3

1.2

22.85

21.22

u/l

0.20

252

1065

Other CVD

125

517

2.44

19.06

1.4

1.2

24.62

29.10

u/l

0.55

103

419

Sequelae of external causes of morbidity and mortality

159

730

2.19

19.01

1.3

1.2

27.30

25.59

u/l

0.16

135

598

Diabetic retinopathy

218

675

2.02

18.99

1.4

1.2

29.75

30.72

u/l

0.10

190

585

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

480

1915

1.59

18.94

1.3

1.2

27.35

26.79

u/l

0.08

412

1607

Syncope and collapse

217

924

1.97

18.88

1.3

1.2

36.32

22.35

u/l

1.96

186

759

Symptoms and signs concerning food and fluid intake

208

3.34

18.87

1.3

1.2

26.54

23.00

u/l

0.22

167

548

1792

1.55

18.79

1.3

1.2

28.72

23.92

u/l

0.84

474

1509

Acute pancreatitis

115

461

2.51

18.77

1.2

46.69

21.26

u/l

2.06

105

373

Obesity, other/unspecified

186

915

2.04

18.56

1.2

1.3

17.64

23.84

u/l

1.53

166

760

Dermatitis

328

1887

1.71

18.47

1.3

1.2

28.34

24.97

u/l

0.37

271

1598

Cardiodefibrillation

192

955

2.02

18.43

1.2

1.3

26.65

28.66

u/l

0.30

165

779

Enlarged lymph nodes

344

2.75

18.42

1.3

1.2

32.20

23.43

u/l

0.66

279

ILD, hospital admissions 3, with pneumonia sepsis

169

3.59

18.32

1.1

1.3

64.62

22.04

u/l

1.57

140

Seropositive rheumatoid arthritis, wide

168

802

2.11

18.21

1.2

22.83

25.89

u/l

0.45

150

660

Benzodiazepine use

490

2126

1.56

18.13

1.3

26.28

26.17

u/l

0.01

409

1810

Chronic periodontitis, complicated

304

1716

1.73

18.12

1.4

1.2

29.58

25.93

u/l

0.38

257

1441

Other/unspecified seropositive rheumatoid arthritis

166

791

2.11

18.09

1.2

22.98

25.64

u/l

0.37

148

653

Parasetamol

306

864

1.79

18.06

1.2

30.55

21.81

u/l

1.00

255

750

Myocardial infarction, without ST-elevation

213

996

1.94

18.01

1.2

1.3

36.19

28.29

u/l

1.04

181

816

Myocardial infarction

258

979

1.85

18.01

1.3

33.81

27.02

u/l

0.95

216

816

Cough

221

1084

1.91

18.00

1.2

20.54

23.16

u/l

0.41

195

909

Other anxiety disorders

231

1043

1.89

17.97

1.2

22.77

22.17

u/l

0.05

194

882

Other/unspecified dorsalgia

203

1029

1.96

17.93

1.2

1.3

22.44

24.94

u/l

0.36

166

855

Other necrotizing vasculopathies (FG)

105

4.35

17.82

1.4

1.1

23.08

17.67

u/l

0.45

Other respiratory diseases principally affecting the interstitium

109

437

2.51

17.82

1.1

1.2

45.45

26.18

u/l

1.05

351

Other reaction to severe stress, and adjustment disorders

188

942

2.00

17.79

1.3

1.2

22.60

22.21

u/l

0.04

166

789

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

447

2215

1.57

17.72

1.2

1.3

25.79

25.84

u/l

0.01

376

1879

Other disorders of glucose regulation and pancreatic internal secretion

159

3.62

17.66

1.4

1.2

34.94

18.80

u/l

1.17

133

Amiodarone users

223

3.18

17.63

1.2

1.3

32.35

23.43

u/l

1.10

183

Vitamin B12 deficiency anaemia

208

3.25

17.58

1.3

1.2

27.30

22.60

u/l

0.33

171

Overexertion and strenuous or repetitive movements

214

3.21

17.47

1.4

1.2

28.16

20.77

u/l

0.73

175

Iron deficiency anaemia secondary to blood loss (chronic)

379

2.61

17.27

1.3

1.2

31.17

21.15

u/l

0.87

308

Benign neoplasms

435

1483

1.60

17.23

1.3

1.2

24.88

26.23

u/l

0.15

363

1268

Obesity

317

1774

1.69

17.11

1.2

1.3

21.42

24.91

u/l

0.79

267

1498

Complications of internal orthopaedic prosthetic devices, implants and grafts

137

619

2.23

17.10

1.3

1.2

29.94

26.79

u/l

0.28

115

504

Obesity and other hyperalimentation

318

1779

1.69

17.09

1.2

1.3

21.35

24.87

u/l

0.81

268

1503

Bronchitis

526

2078

1.52

17.09

1.3

1.2

29.97

24.57

u/l

0.96

459

1747

Abnormalities of gait and mobility

297

2.82

17.04

1.2

30.09

23.74

u/l

0.41

250

Other medical care

241

1107

1.83

17.01

1.4

1.2

44.86

22.33

u/l

3.78

219

911

Irritable bowel syndrome

147

685

2.16

16.97

1.2

26.78

20.69

u/l

0.39

127

576

Invasive ventilation

145

3.70

16.92

1.2

41.21

20.02

u/l

1.28

121

Calcific aortic valvular stenosis, diagnosis (helper)

159

734

2.10

16.92

1.3

1.2

32.95

29.03

u/l

0.44

137

593

Operations 2 for CAVS

159

734

2.10

16.92

1.3

1.2

32.95

29.03

u/l

0.44

137

593

Any death

337

1410

1.68

16.91

1.4

1.2

46.13

21.33

u/l

7.02

300

1160

Chronic ulcer of skin, not elsewhere classified

136

3.80

16.89

1.3

1.2

31.30

20.04

u/l

1.04

112

Arthropathies

396

1226

1.64

16.87

1.2

1.3

21.45

26.31

u/l

0.83

344

1033

Calcific aortic valvular stenosis, operated

159

736

2.09

16.81

1.3

1.2

32.95

28.97

u/l

0.45

137

595

Calcific aortic valvular stenosis

159

736

2.09

16.81

1.3

1.2

32.95

28.97

u/l

0.45

137

595

Open wound of ankle and foot

215

3.15

16.67

1.4

1.2

41.79

24.21

u/l

1.39

177

Calcific aortic valvular stenosis, including rheumatic fever

159

738

2.08

16.64

1.3

1.2

32.95

29.77

u/l

0.34

137

596

Other and unspecified dermatitis

275

1591

1.73

16.59

1.3

1.2

29.05

23.86

u/l

0.55

228

1331

Hernia

458

1967

1.55

16.57

1.3

1.2

26.19

26.24

u/l

0.01

389

1666

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

160

780

2.07

16.46

1.2

22.67

25.95

u/l

0.48

144

644

Hard cardiovascular diseases

413

1536

1.59

16.38

1.3

1.2

26.59

25.11

u/l

0.23

358

1292

Sarcoidosis

315

2.72

16.34

1.2

36.97

23.37

u/l

0.59

256

Abnormal findings on diagnostic imaging of lung

257

1386

1.76

16.28

1.2

31.13

25.64

u/l

0.66

212

1155

Postprocedural disorders of digestive system, not elsewhere classified

5.10

16.24

1.9

1.2

54.62

19.36

u/l

1.07

Senile cataract

327

1184

1.68

16.24

1.3

1.2

31.23

24.46

u/l

1.15

287

989

Need for other prophylactic measures

113

4.04

16.22

1.1

1.2

12.18

16.94

u/l

1.29

Diagnoses used for exclusion with ILD

145

686

2.13

16.15

1.2

33.66

26.77

u/l

0.43

125

558

Diseases of the eye and adnexa

334

992

1.69

16.12

1.3

1.2

22.64

25.86

u/l

0.38

283

843

Other cataract

243

1005

1.80

15.95

1.3

1.2

27.07

24.12

u/l

0.40

208

832

Other antidepressants

469

1551

1.55

15.92

1.2

1.3

26.34

26.99

u/l

0.07

386

1322

Pain (limb, back, neck, head abdominally)

306

891

1.72

15.86

1.2

26.25

27.25

u/l

0.09

255

750

Volume depletion

176

3.32

15.82

1.3

1.2

37.56

24.78

u/l

0.67

143

Hypotension

104

432

2.42

15.80

1.4

1.2

26.39

29.67

u/l

0.32

357

Symptoms and signs involving the skin and subcutaneous tissue

361

2139

1.60

15.77

1.2

1.3

26.38

25.41

u/l

0.11

312

1802

Acute pancreatitis (for exclusion)

115

502

2.31

15.63

1.2

46.69

25.83

u/l

1.46

105

406

Spondylopathies (FG)

261

2.86

15.62

1.2

24.62

23.77

u/l

0.04

215

Mycoses, including avohilmo

443

2206

1.53

15.58

1.3

1.2

31.04

24.34

u/l

1.05

380

1868

Diseases of the musculoskeletal system and connective tissue

209

543

1.93

15.57

1.2

1.3

22.77

24.87

u/l

0.20

172

464

Chronic apical periodontitis

519

1947

1.50

15.51

1.2

1.3

28.93

25.16

u/l

0.60

434

1657

Sequelae with surgical and medical care as external cause

123

555

2.23

15.46

1.3

1.2

28.31

27.36

u/l

0.07

104

455

Valvular operations

269

2.81

15.35

1.4

1.3

44.34

23.18

u/l

1.40

218

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

4.46

15.20

1.0

1.2

59.56

19.76

u/l

2.08

Mycoses

153

757

2.03

15.15

1.4

1.2

48.65

23.65

u/l

2.03

136

618

All influenza (not pneumonia)

272

2.77

15.04

1.4

1.1

32.39

21.90

u/l

0.79

225

Hypoglycaemia, other or unspecified

124

3.75

15.03

1.4

1.2

39.48

19.01

u/l

1.21

103

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

346

2.54

15.03

1.4

1.2

28.66

25.49

u/l

0.22

288

STROKE

263

1023

1.74

14.92

1.3

25.16

23.76

u/l

0.17

221

851

Other metabolic disorders

297

2.68

14.80

1.2

29.35

23.53

u/l

0.31

243

Factors influencing health status and contact with health services

119

252

2.38

14.70

1.2

20.35

23.21

u/l

0.36

207

Myocardial infarction, strict

230

912

1.79

14.67

1.3

1.2

32.15

27.30

u/l

0.54

191

761

Other dorsopathies, not elsewhere classified

445

1512

1.53

14.58

1.2

1.3

24.44

25.99

u/l

0.23

373

1287

Malignant neoplasm of breast, HER-negative

122

539

2.19

14.54

1.3

1.2

21.28

21.65

u/l

0.02

450

Other acute lower respiratory infections

259

1455

1.70

14.52

1.3

34.88

24.83

u/l

1.30

225

1218

Abnormal weight loss

207

3.03

14.49

1.3

1.2

25.31

19.51

u/l

0.61

174

Falls/tendency to fall

466

1542

1.52

14.48

1.3

1.2

25.98

24.61

u/l

0.21

391

1315

Injuries to unspecified part of trunk, limb or body region

213

2.98

14.39

1.3

1.2

33.78

24.20

u/l

0.58

181

Abnormal findings on diagnostic imaging of other body structures

384

2.44

14.39

1.2

30.90

23.07

u/l

0.62

317

AV-block

313

2.50

14.33

1.3

1.2

34.50

24.76

u/l

0.93

256

Major coronary heart disease event excluding revascularizations

304

1220

1.65

14.26

1.3

1.2

30.64

26.73

u/l

0.55

259

1014

Accidents

346

1073

1.62

14.24

1.3

1.2

26.28

24.83

u/l

0.15

292

914

Caries of enamel

453

1977

1.50

14.21

1.3

21.25

25.65

u/l

0.82

382

1675

Soft tissue disorders

445

1499

1.52

14.19

1.3

21.67

25.09

u/l

0.73

374

1271

Psoriasis

158

810

1.96

14.19

1.2

22.21

24.74

u/l

0.29

137

657

Type 2 diabetes, strict (exclude DM1)

429

1641

1.52

14.10

1.2

1.3

25.08

24.77

u/l

0.04

365

1365

Other external causes of accidental injury

345

1073

1.61

14.04

1.3

1.2

23.92

24.83

u/l

0.11

292

914

Depression or dysthymia

312

1038

1.65

13.97

1.3

25.80

28.32

u/l

0.30

261

885

Diabetic neuropathy

311

2.59

13.92

1.3

1.2

40.72

27.34

u/l

0.99

266

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

378

2.40

13.88

1.4

1.2

27.94

25.08

u/l

0.21

315

Conduction disorders

142

560

2.04

13.72

1.2

30.96

24.96

u/l

0.67

129

449

Osteoporosis with pathological fracture (FG)

177

3.14

13.71

1.2

32.43

20.79

u/l

1.07

146

Type 2 diabetes, definitions combined

423

1624

1.52

13.69

1.2

1.3

24.87

24.77

u/l

0.01

359

1352

Other pleural conditions

225

2.87

13.66

1.3

1.2

48.63

27.05

u/l

1.41

187

Hypoparathyroidism

4.48

13.59

1.3

1.2

23.56

14.68

u/l

0.92

Degeneration of macula and posterior pole

251

1145

1.70

13.54

1.3

1.2

29.21

27.89

u/l

0.12

205

965

Seronegative rheumatoid arthritis

260

2.71

13.48

1.2

1.1

22.79

20.27

u/l

0.26

210

Fracture of rib(s), sternum and thoracic spine

162

853

1.91

13.46

1.3

1.2

29.28

28.07

u/l

0.08

134

697

Oesophagitis

3.97

13.44

1.2

43.44

17.89

u/l

0.95

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

4.22

13.43

1.1

1.2

48.83

20.43

u/l

1.15

Other diseases of anus and rectum

152

782

1.94

13.37

1.3

1.2

28.50

24.11

u/l

0.45

127

649

Colectomy operation

429

2.30

13.32

1.4

1.2

36.92

26.25

u/l

0.82

352

Benign neoplasm: Colon, unspecified

142

718

1.99

13.31

1.2

1.3

43.43

25.06

u/l

1.03

116

581

Diseases of the respiratory system

283

850

1.67

13.24

1.2

26.90

20.08

u/l

0.96

244

710

Lymphoid leukaemia

112

3.71

13.20

1.2

46.83

20.07

u/l

1.22

Papulosquamous disorders

207

1183

1.76

13.19

1.3

1.2

22.78

24.12

u/l

0.16

180

974

Injuries to the thorax

225

1316

1.71

13.15

1.3

1.2

28.42

27.42

u/l

0.09

190

1095

Ischemic heart diseases

403

1583

1.52

13.14

1.3

1.2

27.41

25.59

u/l

0.28

341

1340

Malignant neoplasm of breast, ER-negative, including Hilmo

126

571

2.08

13.14

1.3

1.2

21.65

21.70

u/l

0.00

101

477

Persons encountering health services for examination and investigation

255

748

1.71

13.04

1.2

24.70

25.49

u/l

0.06

208

627

Benign neoplasm: Stomach

243

2.74

12.96

1.3

1.2

31.70

22.23

u/l

0.70

202

Emergency coronary revascularization (for ACS)

413

1662

1.50

12.89

1.3

1.2

30.15

24.97

u/l

1.11

350

1400

Other (seronegative) rheumatoid arthritis, wide

115

545

2.12

12.88

1.2

27.03

25.78

u/l

0.10

104

441

Asthma, hospital admissions , main diagnosis only

385

2230

1.50

12.84

1.3

1.2

30.66

24.41

u/l

0.83

329

1887

Any mental disorder

490

1682

1.46

12.81

1.2

1.3

25.29

25.95

u/l

0.09

405

1434

Postprocedural endocrine and metabolic disorders, not elsewhere classified

279

2.60

12.77

1.2

31.30

23.92

u/l

0.38

230

Cyst of kidney

149

3.26

12.72

1.4

1.2

18.69

21.92

u/l

0.26

127

Seropositive rheumatoid arthritis, strict definition

413

2.29

12.70

1.2

18.67

24.80

u/l

0.80

339

Gastric ulcer

413

2.29

12.68

1.2

31.84

29.39

u/l

0.14

332

Percutaneous Coronary Intervention

383

1537

1.52

12.57

1.3

1.2

29.27

24.45

u/l

1.06

325

1297

Acute upper respiratory infections of multiple and unspecified sites

356

1699

1.53

12.56

1.3

1.2

27.35

24.09

u/l

0.42

316

1414

Personality disorders, excluding more controls

117

562

2.09

12.55

1.2

23.13

19.18

u/l

0.35

478

Injuries to the head

510

2113

1.43

12.52

1.2

1.3

27.93

25.28

u/l

0.37

421

1803

Persons with potential health hazards related to communicable diseases

164

881

1.85

12.45

1.3

1.2

30.63

20.49

u/l

0.68

144

743

Malignant neoplasm of digestive organs, including Hilmo

196

812

1.78

12.44

1.2

45.60

22.50

u/l

2.82

168

672

Weight loss

237

2.72

12.44

1.3

25.06

22.08

u/l

0.24

198

Intestinal adhesions without obstruction

172

3.05

12.40

1.2

1.3

45.61

23.85

u/l

1.22

143

Sciatica+with lumbago

246

1322

1.65

12.33

1.3

27.08

25.76

u/l

0.14

204

1118

Tubulo-interstitial nephritis, not specified as acute or chronic

108

3.64

12.31

1.2

36.36

20.33

u/l

0.76

Intestinal malabsorption

3.79

12.29

1.4

1.2

31.17

19.60

u/l

1.06

Fracture of lower leg, including ankle

276

1701

1.60

12.26

1.2

24.46

25.29

u/l

0.10

246

1425

Nonorganic sleeping disorders, excluding more controls

101

464

2.19

12.24

1.2

18.39

21.03

u/l

0.17

392

KRA_PSY_EATING, excluding more controls

3.92

12.24

1.3

16.38

23.44

u/l

0.30

Non-Hodgkin lymphoma, all, including Hilmo

262

2.61

12.22

1.2

61.10

20.32

u/l

1.97

215

Acute bronchitis

202

1149

1.73

12.21

1.3

1.2

33.50

25.14

u/l

0.98

179

946

Dilated cardiomyopathy

251

2.65

12.18

1.2

1.3

42.55

23.31

u/l

2.85

206

Unspecified haematuria

199

930

1.75

12.11

1.2

1.3

40.93

27.66

u/l

1.66

167

765

Other arrhythmias

281

1314

1.60

12.07

1.3

1.2

27.24

23.29

u/l

0.53

238

1100

Exposure to other specified factors

372

2142

1.49

12.00

1.3

1.2

26.19

24.74

u/l

0.16

318

1808

Coronary revascularization (ANGIO or CABG)

380

1538

1.50

11.94

1.3

1.2

29.19

24.44

u/l

1.04

323

1298

Injury of unspecified body region

155

3.13

11.93

1.3

1.2

29.16

17.44

u/l

1.27

133

Conjunctivitis (acute, non atopic), including avohilmo

461

1927

1.45

11.93

1.2

1.3

23.99

26.93

u/l

0.41

386

1633

Ischaemic heart disease, wide definition

375

1535

1.51

11.93

1.3

1.2

28.74

24.51

u/l

0.72

310

1289

Chronic lower respiratory diseases

536

1999

1.41

11.93

1.3

1.2

31.82

23.98

u/l

1.42

443

1704

Dorsopathies

440

1519

1.47

11.90

1.3

21.95

25.91

u/l

0.83

374

1292

Fracture of shoulder and upper arm

193

1114

1.74

11.87

1.3

1.2

30.07

23.20

u/l

1.00

163

926

Acute upper respiratory infections

481

2015

1.43

11.81

1.3

1.2

27.03

25.56

u/l

0.19

420

1690

Early onset COPD, excluding more controls

432

2.21

11.80

1.2

42.96

20.90

u/l

1.35

354

Persistent mood disorders

104

491

2.13

11.80

1.1

1.2

13.47

23.01

u/l

2.14

399

Other orthopaedic follow-up care

102

3.67

11.77

1.3

1.2

21.44

14.69

u/l

0.53

Other (not insulin) diabetes medications

435

1751

1.46

11.77

1.2

26.45

24.62

u/l

0.29

373

1463

ILD, hospital admissions

370

2.31

11.77

1.1

1.3

50.08

25.08

u/l

1.14

304

Other special examinations and investigations of persons without complaint or reported diagnosis

247

748

1.68

11.76

1.2

25.65

25.49

u/l

0.01

208

627

Congenital malformations, deformations and chromosomal abnormalities

260

1540

1.60

11.74

1.3

20.95

23.46

u/l

0.41

222

1297

Other and unspecified local infections of skin and subcutaneous tissue

205

2.80

11.72

1.4

1.2

47.35

24.75

u/l

0.68

169

Chronic rhinitis, nasopharyngitis and pharyngitis

171

959

1.79

11.68

1.3

1.2

17.75

22.04

u/l

0.59

141

794

Alcohol use disorder, Swedish definition

240

1338

1.63

11.62

1.2

1.3

35.74

27.14

u/l

1.10

199

1133

252

1400

1.61

11.50

1.2

1.3

34.53

26.98

u/l

0.98

211

1186

Coronary atherosclerosis

314

1280

1.55

11.47

1.3

1.2

32.41

25.54

u/l

0.99

259

1070

Disorders of synovium and tendon

247

1296

1.62

11.45

1.3

23.84

24.27

u/l

0.03

216

1092

Duodenal ulcer

219

2.71

11.43

1.3

1.2

24.44

25.39

u/l

0.06

175

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

286

1673

1.56

11.43

1.3

21.02

24.24

u/l

0.61

242

1404

Other interstitial pulmonary diseases

376

2.28

11.35

1.1

1.3

50.08

26.40

u/l

1.05

305

Scar conditions and fibrosis of skin

4.16

11.35

1.2

10.39

14.89

u/l

0.93

Candidiasis, including avohilmo

155

853

1.83

11.31

1.3

1.2

43.72

22.25

u/l

1.84

132

703

Interstitial lung disease

377

2.27

11.28

1.1

1.2

50.08

26.47

u/l

1.05

307

Interstitial lung disease endpoints

377

2.27

11.28

1.1

1.2

50.08

26.47

u/l

1.05

307

Disorders of conjunctiva

388

2055

1.47

11.24

1.3

20.66

24.42

u/l

0.53

339

1725

COPD (mode)

141

580

1.90

11.23

1.2

37.17

20.76

u/l

1.49

115

480

Other local infections of skin and subcutaneous tissue

227

2.66

11.22

1.4

1.2

45.82

24.67

u/l

0.66

187

Asthma, including avohilmo

527

2076

1.40

11.21

1.3

1.2

32.49

24.73

u/l

1.37

435

1772

Genitourinary diseases

207

599

1.74

11.19

1.3

25.51

22.97

u/l

0.22

177

502

Conjunctivitis

356

1931

1.49

11.17

1.2

20.89

23.35

u/l

0.28

311

1624

Recurrent or chronic depression

187

743

1.75

11.17

1.2

1.3

28.11

26.15

u/l

0.13

157

632

Arthropathy in ulcerative colitis

10.38

11.10

1.2

19.69

16.38

u/l

0.17

Other joint disorders

354

1225

1.51

11.03

1.2

1.3

21.03

26.34

u/l

0.86

309

1032

ILD, hospital admissions 1, main diag only

325

2.36

10.99

1.1

1.2

53.71

25.76

u/l

1.17

268

Arterial embolism and thrombosis

107

3.49

10.98

1.3

1.2

41.36

25.16

u/l

0.45

Spondylosis

260

1283

1.59

10.95

1.2

29.70

27.20

u/l

0.26

210

1081

Unspecified fall

248

1534

1.59

10.91

1.3

1.2

23.62

26.26

u/l

0.36

214

1284

Major coronary heart disease event

397

1627

1.46

10.90

1.3

1.2

28.23

24.75

u/l

0.70

339

1367

Obesity related asthma

173

997

1.74

10.82

1.3

1.2

30.01

22.05

u/l

0.89

139

830

Injuries to the knee and lower leg

533

2078

1.39

10.79

1.3

1.2

25.72

25.56

u/l

0.02

454

1756

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

177

1028

1.73

10.77

1.2

26.94

23.59

u/l

0.31

151

850

Type 2 diabetes, definitions combined, including avohilmo

410

1636

1.45

10.76

1.2

1.3

24.40

24.63

u/l

0.03

346

1361

Other renal tubulo-interstitial diseases

5.65

10.72

1.2

19.00

17.70

u/l

0.08

Reactive arthropathies

166

2.91

10.64

1.4

1.1

20.17

25.39

u/l

0.34

132

Lung cancer and mesothelioma

351

2.19

10.62

1.2

38.63

24.08

u/l

0.96

288

Other embolism and thrombosis

306

2.37

10.57

1.3

1.2

27.57

23.59

u/l

0.31

247

Disorders of sclera, cornea, iris and ciliary body

258

1656

1.56

10.56

1.3

25.33

25.59

u/l

0.02

234

1369

259

1440

1.57

10.54

1.2

1.3

34.12

26.73

u/l

0.98

216

1219

Zoster [herpes zoster], including avohilmo

263

1636

1.56

10.50

1.3

1.2

33.34

25.43

u/l

0.78

211

1364

Misadventures to patients during surgical and medical care

358

2.25

10.43

1.3

1.2

48.48

23.87

u/l

1.79

301

Non-selective monoamine reuptake inhibitors

188

1073

1.69

10.42

1.2

1.3

30.17

25.68

u/l

0.37

158

893

Other or ill-defined heart diseases

3.71

10.41

1.3

1.2

36.59

23.82

u/l

0.39

Malignant neoplasm of skin, including Hilmo

230

952

1.62

10.33

1.4

1.2

23.59

22.55

u/l

0.13

189

791

Other specified/unspecified bacterial intestinal infections

137

3.10

10.32

1.3

1.2

34.67

19.95

u/l

0.87

113

Urticaria and erythema

177

1043

1.70

10.23

1.2

25.64

22.54

u/l

0.20

154

865

Exposure to other and unspecified inanimate mechanical forces

154

2.95

10.18

1.2

15.25

21.48

u/l

0.54

126

Retention of urine

148

664

1.81

10.18

1.3

33.40

28.36

u/l

0.51

129

546

Malignant neoplasm of digestive organs

171

756

1.73

10.13

1.2

42.80

22.69

u/l

2.91

147

627

Diseases of pulp and periapical tissues, including avohilmo

453

1661

1.41

10.09

1.2

1.3

29.42

26.29

u/l

0.39

368

1412

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

5.08

10.07

1.4

1.2

37.90

24.84

u/l

0.58

Multiple myeloma

5.08

10.07

1.4

1.2

37.90

24.84

u/l

0.58

Substance abuse, excluding more controls

232

1222

1.59

10.00

1.2

1.3

35.46

25.51

u/l

1.30

192

1037

Acute sinusitis

232

1334

1.58

9.98

1.4

1.2

23.46

23.17

u/l

0.03

209

1108

Candidiasis

352

2.23

9.98

1.4

1.2

61.21

23.27

u/l

1.79

291

Reactive arthropathies, FINNGEN

109

3.33

9.98

1.4

1.1

22.16

18.58

u/l

0.26

Symptoms and signs involving the urinary system

352

1824

1.46

9.97

1.3

1.2

31.67

25.53

u/l

0.92

296

1530

Trigger finger

406

2.13

9.85

1.3

1.2

22.05

24.49

u/l

0.19

333

Obesity due to excess calories

214

1338

1.60

9.84

1.2

1.3

24.23

23.32

u/l

0.11

177

1128

Pacemaker

170

929

1.71

9.82

1.3

1.2

37.76

28.21

u/l

1.63

152

754

Venous thromboembolism

259

1629

1.53

9.78

1.3

1.2

29.37

26.67

u/l

0.35

230

1351

Dipeptidyl peptidase 4 (DPP-4) inhibitors

271

1394

1.53

9.72

1.2

1.3

32.99

25.43

u/l

1.15

231

1162

Dizziness and giddiness

345

1848

1.45

9.71

1.2

1.3

24.48

26.97

u/l

0.38

290

1571

Disorders of the thyroid gland

413

1897

1.41

9.69

1.2

1.3

26.15

26.68

u/l

0.06

345

1605

Viral hepatitis, including avohilmo

137

3.02

9.68

1.3

1.2

22.11

25.54

u/l

0.16

114

Retinal detachments and breaks

173

1030

1.69

9.67

1.2

22.56

25.05

u/l

0.40

141

856

Other disorders of lacrimal gland

195

1198

1.63

9.65

1.3

1.2

24.71

23.14

u/l

0.10

161

992

Injuries to the ankle and foot

317

1849

1.47

9.47

1.4

1.2

24.64

24.02

u/l

0.08

273

1563

Benign neoplasm: Sigmoid colon

102

523

1.96

9.35

1.3

1.2

22.66

25.54

u/l

0.33

429

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

375

2.14

9.33

1.2

33.57

23.32

u/l

0.71

311

Other specified and unspecified personality disorders

162

2.80

9.31

1.2

1.1

24.08

25.65

u/l

0.06

136

Panic disorder

293

2.30

9.26

1.2

16.30

22.48

u/l

0.55

246

Hypertrophic cardiomyopathy

3.58

9.24

1.4

1.2

31.56

18.61

u/l

1.51

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

111

569

1.90

9.23

1.8

1.2

42.30

23.46

u/l

2.02

101

472

Other/unspecified rheumatoid arthritis

307

2.26

9.18

1.2

27.70

19.81

u/l

0.93

249

Eating disorder

110

3.19

9.13

1.3

1.2

16.38

24.57

u/l

0.44

101

Nonorganic sleeping disorders

101

521

1.95

9.10

1.2

18.39

22.01

u/l

0.26

443

Disorders of continuity of bone

228

2.47

9.09

1.3

1.2

18.58

25.72

u/l

0.51

193

Thyrotoxicosis, other and/or unspecified

104

543

1.92

9.05

1.2

20.44

24.20

u/l

0.31

448

Intracranial trauma

244

1068

1.55

9.05

1.2

1.3

27.51

28.20

u/l

0.06

203

915

Convulsions, not elsewhere classified

454

2.01

9.05

1.2

30.73

22.37

u/l

0.63

361

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

103

436

1.95

9.02

1.2

42.76

22.76

u/l

1.58

356

Multiple myeloma, including Hilmo

3.68

9.00

1.4

1.2

42.00

20.26

u/l

1.42

Neurological diseases, wide definition

205

2.16

8.98

1.2

1.3

17.67

22.30

u/l

0.47

171

Soft tissue disorders related to use, overuse and pressure

139

798

1.75

8.91

1.3

1.2

18.81

24.86

u/l

1.17

118

663

Hypothyreosis and Thyroxine purchase for inclusion criteria

404

1897

1.40

8.90

1.2

1.3

27.01

25.71

u/l

0.15

342

1595

Protozoal diseases

4.06

8.81

1.2

36.53

20.47

u/l

0.50

Lichen simplex chronicus and prurigo

134

2.94

8.81

1.3

1.2

15.50

20.86

u/l

0.49

110

Disorders of skin appendages

219

1407

1.55

8.80

1.3

1.2

18.23

22.86

u/l

1.09

185

1176

Other arthrosis

233

1008

1.55

8.79

1.2

1.3

26.06

28.08

u/l

0.22

202

844

Macular pucker

425

2.04

8.78

1.4

1.2

32.68

23.84

u/l

0.72

347

Protozoal diseases, including avohilmo

3.99

8.63

1.2

36.53

20.17

u/l

0.51

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

254

1629

1.50

8.58

1.2

21.31

23.23

u/l

0.16

223

1367

Neuromuscular dysfunction of bladder

164

2.70

8.56

1.4

1.2

25.45

19.82

u/l

0.40

136

Viral hepatitis

131

2.92

8.54

1.3

1.2

21.85

25.94

u/l

0.19

109

Malignant neoplasm of prostate

292

1.99

8.52

1.7

1.2

32.08

26.55

u/l

0.28

239

malignant neoplasm of male genital organs

101

310

1.97

8.52

1.7

1.2

34.74

26.46

u/l

0.45

254

Nonischemic cardiomyopathy

205

2.50

8.51

1.2

1.3

26.66

22.77

u/l

0.37

167

Disorders of eyelid, lacrimal system and orbit

393

2082

1.38

8.43

1.3

1.2

26.67

26.54

u/l

0.01

329

1766

Personality disorders

117

650

1.81

8.41

1.2

23.13

20.52

u/l

0.21

547

Fissure and fistula of anal and rectal regions

105

564

1.87

8.41

1.1

1.2

19.27

24.22

u/l

0.74

463

Non-allergic asthma (mode), excluding more controls

401

2.03

8.39

1.3

1.2

32.53

16.94

u/l

1.39

335

Malignant melanoma, including Hilmo

385

2.06

8.39

1.3

1.2

32.93

20.16

u/l

0.97

315

Other disorders of veins

207

1315

1.55

8.36

1.3

1.2

23.29

24.35

u/l

0.16

172

1092

Erosion of teeth , including avohilmo

119

667

1.79

8.31

1.2

36.48

21.06

u/l

0.66

555

Malignant melanoma

340

2.13

8.31

1.3

1.2

33.84

19.94

u/l

0.99

277

Disorders of adult personality and behaviour

122

689

1.78

8.31

1.2

23.09

20.96

u/l

0.17

103

580

Nerve, nerve root and plexus disorders

463

2058

1.35

8.30

1.3

1.2

21.81

27.67

u/l

1.99

400

1736

External causes of morbidity and mortality

255

843

1.52

8.26

1.2

27.87

24.70

u/l

0.29

213

719

Other symptoms and signs involving cognitive functions and awareness

224

1305

1.53

8.21

1.2

1.3

23.82

27.56

u/l

0.56

183

1100

Allergic conjunctivitis

262

1715

1.47

8.21

1.2

21.43

23.04

u/l

0.13

227

1448

Other viral diseases, including avohilmo

157

944

1.65

8.19

1.2

32.57

20.35

u/l

1.01

138

791

Selective serotonin reuptake inhibitors

413

1557

1.38

8.19

1.3

26.25

26.94

u/l

0.08

347

1328

Phobic anxiety disorders

239

2.35

8.18

1.1

1.2

27.10

24.86

u/l

0.09

204

Other viral diseases

122

690

1.77

8.16

1.3

1.2

37.34

20.84

u/l

1.16

112

575

Cerebrovascular diseases

334

1637

1.42

8.13

1.3

1.2

29.21

26.76

u/l

0.31

278

1375

Chronic sinusitis

199

1281

1.56

8.12

1.4

1.2

29.67

24.12

u/l

0.39

171

1065

Non-small cell lung cancer, including Hilmo

296

2.17

8.11

1.1

1.2

37.02

21.10

u/l

0.97

242

Malignant neoplasm of respiratory system and intrathoracic organs

388

1.95

8.06

1.1

1.2

46.49

23.66

u/l

1.57

316

Disorders of vitreous body and globe

256

1646

1.47

8.05

1.3

1.2

22.18

25.05

u/l

0.53

215

1375

Pulmonary heart disease, diseases of pulmonary circulation

154

936

1.65

8.04

1.3

1.2

34.46

27.50

u/l

0.69

136

755

Generalized anxiety disorder

331

2.12

8.02

1.2

18.80

21.87

u/l

0.14

282

Malignant neoplasm of skin

209

912

1.55

8.00

1.3

1.2

23.07

21.30

u/l

0.25

173

755

Memory loss

212

2.42

7.98

1.2

1.3

27.66

22.62

u/l

0.32

172

Dysphagia

119

676

1.77

7.97

1.4

1.3

26.03

24.22

u/l

0.18

553

Procreative management

156

780

1.65

7.94

1.3

1.2

28.40

21.71

u/l

0.41

136

663

Thyrotoxicosis

129

751

1.73

7.93

1.2

22.08

24.05

u/l

0.17

106

622

Superficial injury of head

115

647

1.78

7.92

1.2

27.98

24.10

u/l

0.29

535

Asthma/COPD (KELA code 203)

407

1995

1.36

7.90

1.3

1.2

35.43

24.02

u/l

1.80

343

1701

Disorders of vitreous body

251

1624

1.47

7.90

1.3

1.2

22.30

24.69

u/l

0.41

211

1358

Hypothyroidism, other/unspecified

378

1801

1.38

7.88

1.2

1.3

27.53

26.07

u/l

0.16

319

1516

Functional dyspepsia

123

708

1.74

7.87

1.2

26.44

24.47

u/l

0.12

104

591

Other viral hepatitis

105

3.07

7.85

1.4

1.2

15.52

26.86

u/l

0.62

Other intervertebral disc disorders

337

1426

1.41

7.82

1.2

1.3

24.66

26.75

u/l

0.26

279

1210

Retinal vascular occlusion

264

2.25

7.81

1.2

27.96

26.23

u/l

0.11

222

Ischaemic Stroke, excluding all haemorrhages

256

1280

1.48

7.80

1.2

32.04

27.06

u/l

0.59

217

1065

Other viral hepatitis, including avohilmo

111

3.00

7.77

1.4

1.2

15.18

26.62

u/l

0.67

Transport accidents

183

968

1.58

7.74

1.3

1.2

28.05

24.14

u/l

0.22

150

824

Trochanteric bursitis

432

1.96

7.72

1.3

1.2

20.19

23.21

u/l

0.34

365

Other disorders of skin and subcutaneous tissue, not elsewhere classified

337

2.09

7.72

1.3

1.2

28.38

27.21

u/l

0.07

275

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

439

1.94

7.70

1.2

32.58

23.65

u/l

0.64

363

Retinal vascular disorders

272

2.22

7.70

1.2

29.16

27.28

u/l

0.12

228

Urticaria

138

826

1.68

7.67

1.2

22.41

23.49

u/l

0.08

119

690

Postmenopausal osteoporosis with pathological fracture

163

2.60

7.60

1.2

27.56

22.87

u/l

0.25

131

Cerebral palsy and other paralytic syndromes

243

2.28

7.51

1.6

1.2

22.49

27.99

u/l

0.37

201

Exclusions for E4_PCOS_CONSORTIUM

324

1439

1.41

7.50

1.3

1.2

22.54

23.98

u/l

0.20

274

1212

Squamous cell neoplasms and carcinomas of the skin

176

2.51

7.46

1.2

25.87

23.14

u/l

0.21

139

Non-allergic asthma (mode)

419

1.95

7.46

1.3

1.2

32.53

18.81

u/l

1.14

347

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

219

2.34

7.45

1.3

1.2

23.29

23.80

u/l

0.03

183

Non-small cell lung cancer

186

2.46

7.44

1.2

35.03

21.49

u/l

0.85

149

Discitis, unspecified

6.08

7.42

1.4

1.2

41.42

23.58

u/l

0.80

Other secondary coxarthrosis

3.47

7.41

1.2

82.28

17.63

u/l

0.83

Hydronephrosis

207

2.38

7.41

1.3

1.2

25.39

21.17

u/l

0.29

169

Vocal cord dysfunction

164

2.48

7.40

1.3

15.32

19.77

u/l

0.28

133

Other disorders of bone

447

1.91

7.33

1.3

1.2

27.67

23.23

u/l

0.37

374

Exclusions for E4_PCOS_BROAD

412

1.95

7.32

1.3

1.2

27.46

26.47

u/l

0.07

344

Open wound of head

235

1506

1.47

7.30

1.2

1.3

27.34

26.92

u/l

0.04

196

1281

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

225

2.30

7.26

1.3

1.2

27.09

22.49

u/l

0.45

180

Coronary artery bypass grafting

102

416

1.82

7.25

1.3

37.01

29.36

u/l

0.45

351

Congenital malformations and deformations of the musculoskeletal system

160

2.56

7.25

1.3

1.2

8.46

20.08

u/l

1.56

137

Other and unspecified psoriasis

150

2.62

7.20

1.2

26.69

18.59

u/l

0.43

123

Diabetic maculopathy

307

2.07

7.19

1.4

1.2

28.02

26.00

u/l

0.16

261

Benign neoplasm: Adrenal gland

186

2.44

7.17

1.3

1.2

19.74

20.94

u/l

0.07

154

Stroke, excluding SAH

267

1343

1.44

7.14

1.3

1.2

30.90

26.79

u/l

0.50

228

1123

Obsessive-compulsive disorder

3.13

7.12

1.3

1.2

12.57

24.76

u/l

0.65

Allergic asthma (mode), excluding more controls

447

1.88

7.11

1.3

1.2

27.80

15.32

u/l

1.00

367

Spinal stenosis

230

1151

1.48

7.08

1.2

28.08

26.05

u/l

0.21

189

969

Biguanides

416

1880

1.34

7.02

1.2

1.3

29.53

25.80

u/l

0.59

356

1578

Sleep disorders (combined)

471

1868

1.32

7.01

1.2

1.3

25.26

26.04

u/l

0.10

383

1597

Visual disturbances and blindness

237

1635

1.45

7.01

1.3

1.2

22.53

25.13

u/l

0.39

198

1364

Calculus of kidney and ureter

128

771

1.67

7.00

1.3

21.33

26.71

u/l

0.79

105

632

Thiazolidinediones

264

2.17

6.98

1.2

1.3

34.71

22.24

u/l

0.78

221

Unspecified acute lower respiratory infection

338

2.02

6.92

1.3

1.2

41.05

21.53

u/l

0.91

274

Polyuria

557

1.78

6.92

1.4

1.3

35.65

22.74

u/l

0.85

455

Stomatitis and related lesions

528

1.81

6.92

1.3

1.2

38.77

23.98

u/l

1.05

443

Viral infections characterized by skin and mucous membrane lesions

187

1234

1.52

6.91

1.3

1.2

27.87

25.65

u/l

0.15

166

1028

Inflammatory diseases of the central nervous system

171

2.47

6.91

1.2

23.94

18.19

u/l

0.48

139

Malignant neoplasm of prostate, including Hilmo

302

1.86

6.89

1.8

1.2

32.93

26.75

u/l

0.31

248

Fracture of forearm

262

1657

1.42

6.88

1.3

1.2

18.16

23.64

u/l

2.00

215

1401

Fall involving bed

3.47

6.85

1.1

1.3

47.89

22.67

u/l

0.58

Abscess of anal and rectal regions

148

2.58

6.85

1.2

16.07

19.18

u/l

0.25

120

Other and unspecified injuries of head

154

2.55

6.84

1.1

1.2

18.53

17.58

u/l

0.07

129

Mental and behavioural disorders due to psychoactive substance use

240

1527

1.44

6.80

1.2

1.3

34.41

25.61

u/l

1.16

200

1293

Concussion

203

1054

1.50

6.76

1.2

1.3

28.27

28.53

u/l

0.02

171

902

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

196

875

1.51

6.76

1.4

1.2

25.39

21.71

u/l

0.53

158

721

Rash and other nonspecific skin eruption

229

2.24

6.75

1.3

1.2

19.02

19.33

u/l

0.03

190

Pruritus

288

2.10

6.73

1.2

42.26

21.23

u/l

0.63

241

Special screening examination for infectious and parasitic diseases

299

1.93

6.71

1.2

28.00

20.80

u/l

0.35

249

Mental disorders, not otherwise specified

144

2.58

6.69

1.2

13.93

22.66

u/l

0.75

116

Secondary uncertain malignant neoplasm

256

2.16

6.67

1.3

1.2

54.02

20.11

u/l

1.98

209

Substance abuse

232

1495

1.44

6.65

1.2

1.3

35.46

25.62

u/l

1.30

192

1269

Eating disorders

156

2.51

6.64

1.2

19.70

22.76

u/l

0.17

139

Malignant neoplasm of bronchus and lung, including Hilmo

400

1.84

6.63

1.2

36.03

23.38

u/l

0.96

324

Abnormalities of heart beat

154

954

1.57

6.61

1.2

1.3

28.94

22.12

u/l

0.86

131

795

Thyrotoxicosis with toxic multinodular goitre

140

2.59

6.54

1.2

34.21

17.32

u/l

0.67

117

Undetermined asthma, excluding more controls

278

2.09

6.51

1.4

1.1

40.67

17.43

u/l

0.78

225

Retinal detachment with retinal break

299

2.05

6.48

1.2

20.52

24.03

u/l

0.38

246

Carbimazole or st.post thyroidectomy, condition for graves disease

102

591

1.73

6.48

1.1

1.2

21.22

22.73

u/l

0.09

490

Zoster [herpes zoster]

525

1.78

6.46

1.3

1.2

31.58

28.18

u/l

0.21

426

Visual disturbances

218

1507

1.45

6.46

1.3

22.56

24.29

u/l

0.22

181

1256

Injuries to the elbow and forearm

316

1988

1.36

6.46

1.2

1.3

18.25

25.59

u/l

3.54

260

1683

Isolated proteinuria with specified morphological lesion

7.58

6.46

1.1

1.3

18.86

20.15

u/l

0.06

Unstable angina pectoris

155

778

1.57

6.45

1.2

35.74

28.63

u/l

0.72

133

635

Benign neoplasm: Transverse colon

273

2.10

6.45

1.3

1.2

40.76

24.18

u/l

0.51

223

Angina pectoris

247

1148

1.43

6.39

1.2

33.52

25.41

u/l

1.07

212

960

Keratitis

157

1017

1.55

6.39

1.3

1.2

27.86

24.30

u/l

0.29

143

839

Thyroiditis, ILD-related definition

241

2.17

6.39

1.3

1.2

13.60

21.08

u/l

0.94

197

malignant neoplasm of male genital organs, including Hilmo

316

1.81

6.38

1.8

1.2

36.59

26.17

u/l

0.54

259

Polymyalgia rheumatica

342

1.97

6.37

1.1

1.2

25.20

23.44

u/l

0.16

282

Benign neoplasm: Rectum

477

1.81

6.35

1.2

24.74

25.31

u/l

0.03

391

Basal cell carcinoma, including Hilmo

189

854

1.50

6.30

1.3

1.2

26.08

21.87

u/l

0.62

155

703

Benign neoplasm of other and unspecified endocrine glands

337

1.97

6.28

1.3

1.2

22.53

24.36

u/l

0.12

281

Melanocytic naevi

140

888

1.58

6.26

1.3

1.2

24.25

22.96

u/l

0.11

116

734

Fracture of skull and facial bones

524

1.76

6.21

1.3

1.2

39.13

22.74

u/l

0.88

437

Degenerative macular diseases

284

2.05

6.20

1.3

1.2

18.31

24.14

u/l

0.74

236

In situ neoplasms

187

1266

1.48

6.20

1.2

30.70

25.57

u/l

0.46

162

1051

Disorders of lacrimal system

213

1454

1.44

6.19

1.3

1.2

24.77

23.60

u/l

0.08

176

1208

Specific personality disorders

532

1.75

6.19

1.2

23.13

21.52

u/l

0.12

446

Allergic asthma (mode)

469

1.79

6.16

1.3

1.2

27.80

17.85

u/l

0.72

386

Diffuse large B-cell lymphoma

2.93

6.16

1.3

1.2

35.11

19.44

u/l

1.15

Diffuse large B-cell lymphoma, including Hilmo

2.93

6.16

1.3

1.2

35.11

19.44

u/l

1.15

Diffuse large B-cell lymphoma, helper endpoint

2.93

6.16

1.3

1.2

35.11

19.44

u/l

1.15

Deforming dorsopathies

127

790

1.61

6.16

1.3

22.40

23.36

u/l

0.10

111

656

Urolithiasis

134

845

1.59

6.15

1.3

20.87

26.65

u/l

0.95

109

701

Pulmonary embolism

134

845

1.59

6.15

1.3

1.2

33.87

27.43

u/l

0.55

121

680

Mental and behavioural disorders due to alcohol, excluding acute intoxication

172

1139

1.50

6.07

1.2

1.3

38.94

26.38

u/l

1.26

140

955

Psoriasis vulgaris

484

1.78

6.07

1.2

26.47

25.76

u/l

0.04

396

Malignant neoplasm of bronchus and lung

341

1.87

6.05

1.1

1.2

39.25

22.28

u/l

1.18

279

Mental and behavioural disorders due to alcohol

198

1296

1.46

6.03

1.2

1.3

35.66

26.24

u/l

1.02

164

1096

Covid-19 suspected case

507

1.76

6.02

1.3

1.2

30.70

21.03

u/l

0.75

425

Benign neoplasm: Rectum, anus and anal canal

545

1.73

5.99

1.2

28.11

25.50

u/l

0.15

443

Myalgia

107

643

1.67

5.97

1.3

1.2

25.85

23.01

u/l

0.20

535

Pulmonary heart disease

134

853

1.58

5.93

1.3

1.2

33.87

27.36

u/l

0.56

121

686

Delirium, not induced by alcohol and other psychoactive substances

302

1.99

5.92

1.2

35.81

23.47

u/l

0.82

245

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

197

2.25

5.91

1.2

60.65

18.01

u/l

1.13

163

Bronchiectasis

191

2.27

5.89

1.4

1.2

29.92

22.92

u/l

0.24

158

Shoulder lesions

303

1333

1.36

5.89

1.2

1.3

24.33

26.64

u/l

0.35

254

1121

Infection due to other mycobacteria

6.48

5.88

1.7

1.2

45.93

15.31

u/l

0.76

Malignant neoplasm of pancreas, including Hilmo

160

2.39

5.87

1.2

70.09

20.37

u/l

1.27

133

Monoamine oxidase A inhibitors

305

1.98

5.81

1.2

1.3

27.94

23.74

u/l

0.16

251

Emotionally unstable personality disorder

218

2.16

5.80

1.1

1.2

19.95

21.47

u/l

0.10

187

Benign neoplasm: Skin of trunk

2.89

5.79

1.5

1.2

22.60

18.51

u/l

0.27

Other other unspecified disorders of the circulatory system

3.10

5.78

1.3

1.2

14.38

19.36

u/l

0.40

Other complications of surgical and medical care, not elsewhere classified

212

2.18

5.77

1.2

57.69

23.75

u/l

0.87

175

Psychiatric diseases

396

1513

1.31

5.77

1.2

1.3

26.90

25.82

u/l

0.11

326

1284

Cholecystitis

320

1.95

5.75

1.5

1.2

37.11

22.96

u/l

0.85

257

Asthma and allergy, excluding more controls

216

2.16

5.73

1.3

1.1

25.82

15.79

u/l

0.37

177

Other disorders of eye and adnexa

356

1.89

5.71

1.4

1.2

14.78

26.32

u/l

1.59

303

Coxarthrosis [arthrosis of hip](FG)

227

1106

1.41

5.64

1.3

27.86

25.69

u/l

0.19

192

927

Macular hole

133

2.50

5.62

1.2

16.48

22.85

u/l

0.57

112

Other malignant neoplasms of skin (=non-melanoma skin cancer)

183

845

1.47

5.61

1.3

1.2

24.35

21.91

u/l

0.31

150

695

Undetermined asthma

295

1.97

5.60

1.4

1.1

40.67

20.57

u/l

0.63

240

Asthma and allergy

218

2.13

5.60

1.3

1.2

25.82

15.84

u/l

0.37

179

Other and unspecified drugs and medicaments

189

2.24

5.60

1.2

61.40

24.17

u/l

0.84

158

Psoriatic arthropathies

228

2.12

5.59

1.3

1.2

13.79

19.23

u/l

0.79

179

Stroke, including SAH

274

1441

1.37

5.59

1.3

1.2

30.60

27.16

u/l

0.40

232

1209

Vitamin deficiency, wide

2.82

5.57

1.5

1.2

21.73

18.42

u/l

0.25

Vitamin deficiency

2.82

5.57

1.5

1.2

21.73

18.42

u/l

0.25

Hernia of abdominal wall

188

1303

1.45

5.57

1.3

33.99

25.98

u/l

0.85

166

1076

Infection due to other mycobacteria, including avohilmo

5.93

5.55

1.7

1.2

45.93

16.76

u/l

0.71

Subjective visual disturbances

117

734

1.60

5.54

1.2

19.21

25.43

u/l

1.13

609

Dental caries, including avohilmo

295

1112

1.36

5.51

1.2

29.09

26.33

u/l

0.25

243

942

Other specified and unspecified disorders of eye and adnexa

3.09

5.50

1.6

1.2

12.88

16.05

u/l

0.30

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

184

2.24

5.50

1.3

1.2

38.91

21.36

u/l

1.11

148

COPD, hospital admissions 3, with asthma pneumonia sepsis

116

620

1.61

5.50

1.2

35.58

29.35

u/l

0.41

500

Voice disturbances

127

815

1.56

5.47

1.3

1.2

24.53

25.01

u/l

0.04

111

674

Corneal scars and opacities

3.50

5.46

1.3

1.2

26.44

18.05

u/l

0.49

Other arterial embolism and thrombosis

3.50

5.46

1.3

1.2

62.08

24.65

u/l

0.54

Malignant neoplasm of urinary organs, including Hilmo

217

2.13

5.46

1.3

1.2

35.89

20.91

u/l

1.06

175

Other/unspecified reactive arthropathies

129

2.50

5.45

1.4

1.2

21.00

16.14

u/l

0.42

108

Delivery

785

0.60

5.44

1.3

1.2

24.22

25.60

u/l

0.07

673

Malignant neoplasm of kidney, except renal pelvis

166

2.30

5.43

1.3

1.2

31.30

22.49

u/l

0.53

136

Carcinoma in situ of skin

212

2.14

5.38

1.1

1.3

37.53

21.98

u/l

0.79

173

Aortic aneurysm

507

1.71

5.37

1.2

1.3

31.44

26.82

u/l

0.41

417

Other peripheral vascular diseases

167

2.29

5.36

1.2

57.50

18.27

u/l

0.73

142

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

224

2.09

5.35

1.3

1.2

11.87

22.43

u/l

1.43

195

Erectile dysfunction

161

2.31

5.35

1.3

33.10

27.23

u/l

0.30

135

Behavioural syndromes associated with physiological disturbances and physical factors

397

2088

1.29

5.33

1.2

1.3

26.97

24.71

u/l

0.27

329

1777

Sacroiliitis, not elsewhere classified

3.19

5.32

1.3

1.2

18.60

29.14

u/l

0.33

Coxarthrosis

207

940

1.42

5.30

1.3

27.63

27.96

u/l

0.02

173

785

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

40.40

—

u/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

119

2.54

5.29

1.3

1.2

37.88

22.34

u/l

0.55

Acute pharyngitis

278

1.96

5.28

1.4

1.2

17.74

23.06

u/l

0.46

227

Later onset COPD, excluding more controls

358

1.75

5.26

1.1

1.3

24.50

22.21

u/l

0.23

297

Single spontaneous delivery

785

0.60

5.22

1.3

1.2

33.16

25.60

u/l

0.29

673

DVT of lower extremities and pulmonary embolism

183

1273

1.43

5.22

1.3

1.2

29.53

27.05

u/l

0.24

169

1046

Arthropathic psoriasis

269

1.98

5.20

1.2

15.91

25.44

u/l

0.99

216

Basal cell carcinoma

176

824

1.46

5.19

1.3

1.2

25.67

21.96

u/l

0.50

146

679

Neurological diseases

330

1254

1.32

5.15

1.2

1.3

22.93

27.45

u/l

0.70

275

1073

N06DA Anticholinesterases

879

0.56

5.14

1.1

1.2

23.80

30.39

u/l

0.68

730

Use of anticholinesterases

879

0.56

5.14

1.1

1.2

23.80

30.39

u/l

0.68

730

Renal agenesis and other reduction defects of kidney, including avohilmo

13.80

5.12

1.4

1.3

25.88

15.33

u/l

—

Viral warts, including avohilmo

548

1.67

5.11

1.2

14.81

23.08

u/l

1.79

462

Dislocation, sprain and strain of joint and ligaments of hip

2.87

5.09

1.3

22.35

19.20

u/l

0.15

Myocardial infarction, with ST-elevation

392

1.79

5.09

1.2

1.3

42.32

27.32

u/l

0.80

314

Disturbances of skin sensation

118

760

1.56

5.04

1.3

1.2

26.39

23.84

u/l

0.15

103

628

Family history of malignant neoplasm

245

2.01

5.02

1.4

1.2

16.88

21.35

u/l

0.35

209

Follicular cysts of skin and subcutaneous tissue

476

1.71

4.99

1.3

1.2

17.81

25.98

u/l

1.40

390

Other and unspecified urticaria

492

1.69

4.96

1.3

1.2

23.86

22.93

u/l

0.05

410

Melanocytic naevi of trunk

274

1.94

4.95

1.2

33.81

22.95

u/l

0.51

230

Lumbar disc prolapse

253

1386

1.35

4.95

1.2

1.3

25.84

26.28

u/l

0.04

206

1172

Caries of dentine, including avohilmo

318

1232

1.32

4.95

1.2

24.74

26.72

u/l

0.25

266

1044

Other diseases of hard tissues of teeth

216

798

1.40

4.95

1.2

30.02

26.46

u/l

0.28

175

676

Fall on same level involving ice and snow

249

1849

1.35

4.94

1.2

1.3

25.89

24.59

u/l

0.15

208

1548

Fibroblastic disorders

100

623

1.61

4.93

1.3

26.69

25.46

u/l

0.09

515

Malignant neoplasm of urinary organs

180

2.18

4.93

1.3

1.2

30.39

21.97

u/l

0.52

145

Alcohol use disorder, ICD-based

156

1071

1.46

4.92

1.2

1.3

36.91

26.71

u/l

0.96

127

900

Radiculopathy

419

1.75

4.90

1.2

22.79

25.33

u/l

0.19

336

Melanoma in situ

100

2.62

4.90

1.2

39.95

21.06

u/l

0.59

Dermatophytosis, including avohilmo

265

1949

1.33

4.89

1.2

1.3

24.07

25.00

u/l

0.09

230

1635

Carrier of infectious disease

4.60

4.88

1.1

1.3

18.27

14.71

u/l

0.25

Superficial injury of abdomen, lower back and pelvis

347

1.82

4.85

1.3

1.2

20.91

21.60

u/l

0.05

282

Progressive vascular leukoencephalopathy

2.72

4.85

1.2

17.26

25.16

u/l

1.00

Recurrent aphthous stomatitis , including avohilmo

362

1.80

4.84

1.3

1.2

37.21

25.71

u/l

0.55

299

General examination and investigation of persons without complaint and reported diagnosis

203

747

1.41

4.83

1.3

1.2

31.61

25.51

u/l

0.49

171

626

COPD

188

1083

1.41

4.83

1.2

33.31

26.14

u/l

0.67

155

899

Injuries to the shoulder and upper arm

362

2182

1.28

4.82

1.3

1.2

29.72

25.96

u/l

0.56

308

1848

Injury, poisoning and certain other consequences of external causes

199

704

1.42

4.82

1.2

30.07

24.57

u/l

0.42

167

605

Malignant melanoma of skin, including Hilmo

305

1.88

4.81

1.4

1.2

26.24

20.45

u/l

0.56

247

Hemiplegia

101

2.59

4.80

1.5

1.2

26.37

20.76

u/l

0.33

COPD, hospital admission 2, with asthma infections

135

776

1.50

4.80

1.1

1.3

37.63

30.43

u/l

0.46

111

633

Early onset COPD

589

1.62

4.79

1.2

1.3

42.96

24.97

u/l

1.01

483

Spondylopathies in diseases classified elsewhere

5.83

4.78

1.4

1.3

22.83

27.60

u/l

0.17

Other and unspecified injuries of lower leg

163

2.22

4.77

1.2

29.63

23.49

u/l

0.25

137

Other specified/unspecified hearing loss

230

2.01

4.74

1.2

15.87

21.03

u/l

0.64

194

Pain in thoracic spine

394

1.76

4.73

1.1

1.2

22.76

25.79

u/l

0.21

324

Other viral diseases, not elsewhere classified

415

1.73

4.72

1.4

1.2

31.39

23.61

u/l

0.46

349

Other respiratory disorders and diseases

515

1.66

4.70

1.4

1.2

38.47

26.19

u/l

1.03

420

Other diseases of the respiratory system

515

1.66

4.70

1.4

1.2

38.47

26.19

u/l

1.03

420

Pneumonia derived septicemia

3.04

4.68

1.5

1.2

31.79

21.31

u/l

0.41

Adverse effects, not elsewhere classified

493

1.67

4.67

1.3

1.2

30.54

22.96

u/l

0.26

417

Phlebitis and thrombophlebitis (not including DVT)

601

1.60

4.66

1.2

29.64

24.55

u/l

0.51

489

Use of pramipexole

102

648

1.58

4.66

1.3

1.2

18.87

25.42

u/l

0.86

535

Disorders of tooth development and eruption

301

1.79

4.65

1.4

1.3

35.27

21.20

u/l

0.47

250

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

311

1.80

4.65

1.3

1.2

13.33

21.20

u/l

0.79

262

Diseases of oral cavity, salivary glands and jaws

216

804

1.39

4.62

1.2

25.57

26.40

u/l

0.07

173

682

Delivery, wide proxy

631

0.59

4.61

1.3

1.2

17.03

26.83

u/l

2.34

541

Fenamates

265

1.78

4.61

1.1

1.3

25.76

27.80

u/l

0.09

234

Sulfonylureas

142

768

1.47

4.56

1.3

39.77

26.76

u/l

1.86

127

624

Secondary right heart disease

2.74

4.52

1.3

1.2

35.35

24.86

u/l

0.72

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

621

1.58

4.52

1.2

35.46

19.94

u/l

0.96

528

COPD related to multimorbidity

162

960

1.43

4.50

1.1

1.3

34.81

30.77

u/l

0.27

133

786

Symptoms and signs involving speech and voice

150

1042

1.44

4.49

1.3

1.2

24.02

25.20

u/l

0.11

130

861

Mental and behavioural disorders due to opioids

3.17

4.49

1.2

35.53

29.43

u/l

0.12

Iridocyclitis

615

1.58

4.49

1.2

26.50

26.23

u/l

0.02

500

Anorexia (incl.atypical)

2.66

4.48

1.2

18.82

18.73

u/l

0.00

Intracranial injury

233

1621

1.34

4.48

1.2

27.50

25.57

u/l

0.18

193

1374

Bipolar affective disorders

416

1.71

4.47

1.2

32.16

20.78

u/l

0.60

345

Other chronic obstructive pulmonary disease

180

1053

1.40

4.46

1.2

34.32

25.86

u/l

0.80

148

874

Other viral diseases, not elsewhere classified, including avohilmo

103

659

1.56

4.45

1.3

1.2

26.90

20.72

u/l

0.49

551

Other follicular disorders

136

2.29

4.45

1.2

27.39

23.03

u/l

0.11

117

Atopic dermatitis

230

1362

1.35

4.44

1.3

28.30

21.66

u/l

0.54

197

1152

Somatoform disorder

417

1.71

4.43

1.3

1.2

30.34

22.58

u/l

0.40

349

Ventral hernia

105

680

1.55

4.43

1.3

1.2

36.70

26.28

u/l

0.69

553

Other enthesopathy of foot (+metatarsalgia)

264

1.90

4.43

1.3

1.2

32.10

23.20

u/l

0.37

225

Autoimmune hyperthyroidism

106

2.47

4.38

1.2

1.1

19.00

23.09

u/l

0.15

Other and unspecified visual disturbances

245

1.93

4.33

1.1

1.2

23.60

24.59

u/l

0.06

202

Acute and subacute iridocyclitis

496

1.64

4.33

1.2

25.47

25.25

u/l

0.01

406

Other diseases of lip and oral mucosa

184

1335

1.38

4.32

1.2

24.14

22.73

u/l

0.13

146

1115

Other pulmonary heart/vessel disease

2.55

4.30

1.3

1.2

38.68

24.29

u/l

0.95

Barrett oesophagus

101

2.49

4.30

1.1

30.25

19.51

u/l

0.44

Faecal incontinence

260

1.89

4.29

1.3

1.2

23.97

28.04

u/l

0.24

208

Other disorders of cornea

225

1.97

4.29

1.1

1.2

26.55

23.30

u/l

0.19

187

Gonarthrosis [arthrosis of knee](FG)

284

1251

1.31

4.28

1.2

1.3

21.60

27.47

u/l

1.30

233

1057

Dementia in Alzheimer disease

426

0.41

4.25

1.0

1.2

32.56

29.80

u/l

0.11

352

Hyperaldosteronism

3.07

4.25

1.2

18.92

17.53

u/l

0.09

Arthrosis

261

1082

1.32

4.24

1.2

1.3

26.49

28.05

u/l

0.12

221

902

Anterior Iridocyclitis

538

1.60

4.23

1.2

24.89

24.30

u/l

0.04

444

Diseases of the myoneural junction and muscle

290

1.84

4.23

1.2

29.28

23.34

u/l

0.52

240

Multiple myeloma and malignant plasma cell neoplasms

108

2.43

4.23

1.5

1.2

41.42

23.82

u/l

0.97

Poisoning by drugs, medicaments and biological substances

585

1.58

4.22

1.2

35.36

21.89

u/l

0.83

492

Other inflammation of eyelid

401

1.70

4.21

1.3

1.2

15.00

22.52

u/l

1.67

332

Superficial injury of hip and thigh

356

1.75

4.21

1.4

1.2

27.66

25.87

u/l

0.12

290

Unspecific neurodegenerative disorder

966

0.64

4.20

1.1

1.2

28.39

30.04

u/l

0.12

806

Metatarsalgia

241

1.92

4.19

1.3

1.2

31.89

24.23

u/l

0.28

204

Other blood glucose lowering drugs, excl. Insulins

432

1.67

4.18

1.2

25.53

25.49

u/l

0.00

351

Single delivery by forceps and vacuum extractor

251

0.36

4.16

1.1

1.3

6.00

28.24

u/l

4.16

222

Sequelae of injuries of lower limb

207

1.99

4.16

1.2

26.18

21.10

u/l

0.25

172

Pustulosis palmaris et plantaris

2.55

4.14

1.2

1.1

18.65

22.01

u/l

0.16

Alcohol dependence

620

1.55

4.13

1.1

1.3

44.00

27.30

u/l

1.04

513

Superficial injury of lower leg

108

717

1.51

4.10

1.3

1.2

35.90

24.72

u/l

0.52

596

Viral pneumonia (known virus, not influenza)

3.11

4.09

1.6

1.3

26.36

22.02

u/l

0.18

Malignant neoplasm of oral cavity, including Hilmo

2.72

4.08

1.3

1.1

49.00

21.15

u/l

0.45

Unspecified lump in breast

497

1.62

4.07

1.3

1.2

21.60

25.24

u/l

0.25

414

Benign neoplasm: Ascending colon

375

1.71

4.07

1.2

37.38

23.74

u/l

0.74

309

Arterial embolism and thrombosis of lower extremity artery

2.88

4.06

1.2

1.3

23.15

25.08

u/l

0.07

Colonic or urogenital fistula

112

751

1.50

4.06

1.1

1.2

18.79

24.82

u/l

1.01

617

Poisoning by medicine

521

1.60

4.04

1.2

37.48

22.33

u/l

0.84

439

Other skin changes

553

1.58

4.03

1.2

23.66

26.12

u/l

0.24

454

Pregnancy, childbirth and the puerperium

532

0.59

4.00

1.3

1.2

17.88

28.14

u/l

1.97

452

Episodal and paroxysmal disorders

436

1795

1.23

4.00

1.3

25.99

26.36

u/l

0.04

357

1537

Localized swelling, mass and lump of skin and subcutaneous tissue

134

934

1.44

3.99

1.2

1.3

29.70

23.67

u/l

0.45

115

767

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

109

2.35

3.98

1.3

1.2

9.71

24.59

u/l

1.15

Psoriatic arthropathies, ICD10

260

1.86

3.98

1.3

1.2

13.79

25.12

u/l

1.41

211

Idiopathic thrombocytopenic purpura

3.05

3.97

1.3

1.2

28.62

17.59

u/l

0.55

Diseases of pulp and periapical tissues and dental caries

253

986

1.32

3.97

1.2

27.47

27.43

u/l

0.00

209

834

Other infective otitis externa

124

2.27

3.96

1.3

1.2

14.62

16.29

u/l

0.14

104

COPD, hospital admissions

180

1110

1.37

3.94

1.2

1.3

34.32

29.35

u/l

0.39

148

911

Haemorrhoids and perianal venous thrombosis

128

881

1.45

3.92

1.3

1.2

32.87

23.29

u/l

0.58

109

730

Other diseases of oesophagus

184

2.02

3.92

1.4

1.1

19.76

18.42

u/l

0.11

149

Diseases of salivary glands

138

972

1.42

3.90

1.3

1.2

23.92

23.85

u/l

0.01

119

805

Thyrotoxicosis with diffuse goitre

365

1.71

3.89

1.2

17.53

23.05

u/l

0.56

305

Atrophic disorders of skin

465

1.62

3.87

1.2

19.26

25.80

u/l

0.47

386

Hypothyroidism, strict autoimmune, 3 medication purchases required

339

1815

1.26

3.86

1.3

25.07

25.13

u/l

0.01

290

1518

Other and unspecified vascular occlusions

213

1.93

3.86

1.2

29.40

23.13

u/l

0.41

179

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

344

1.72

3.84

1.3

1.2

41.56

19.76

u/l

1.41

283

Other disorders of the musculoskeletal system and connective tissue

382

1.68

3.83

1.4

1.2

23.34

26.44

u/l

0.25

316

Other chronic obstructive pulmonary disease, including avohilmo

221

1377

1.32

3.81

1.1

1.3

32.52

27.80

u/l

0.43

182

1148

Chondrocostal junction syndrome [Tietze]

2.62

3.81

1.3

1.2

41.05

16.78

u/l

1.44

Substance use, excluding alcohol

467

1.61

3.80

1.2

38.59

23.09

u/l

0.80

393

Conjunctivitis (acute, non atopic)

113

767

1.47

3.80

1.2

26.08

23.77

u/l

0.09

101

632

Congenital malformations of genital organs

165

2.06

3.79

1.1

1.2

13.55

20.55

u/l

0.68

145

Ingrowing nail

108

2.33

3.76

1.4

1.2

20.80

17.08

u/l

0.30

Sleep apnoea

390

1995

1.23

3.75

1.2

1.3

21.73

26.81

u/l

1.56

324

1691

COPD, early/later onset

180

1118

1.35

3.70

1.2

34.32

29.26

u/l

0.40

148

919

Hypotension due to drugs

5.07

3.70

1.1

1.2

27.50

20.67

u/l

—

Complications of the puerperium, not elsewhere classified

2.87

3.63

1.4

1.1

10.63

29.35

u/l

0.70

Other congenital malformations, including avohilmo

269

1.79

3.59

1.3

1.2

13.72

22.28

u/l

1.23

232

Bacterial, viral and other infectious agents, including avohilmo

177

1.99

3.58

1.3

1.2

28.04

22.98

u/l

0.25

151

Lung diseases due to external agents

299

1.74

3.57

1.2

29.68

27.85

u/l

0.09

241

Symptoms and signs involving the nervous and musculoskeletal systems

235

1822

1.29

3.57

1.3

1.2

28.78

24.87

u/l

0.39

190

1531

Ocular pain

184

1.97

3.57

1.2

11.77

23.90

u/l

1.48

159

Fracture of foot, except ankle

643

1.50

3.55

1.4

1.2

25.54

21.84

u/l

0.32

537

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

127

898

1.42

3.55

1.2

1.3

24.24

22.30

u/l

0.18

110

742

Glucagon-like peptide-1 (GLP-1) analogues

127

898

1.42

3.55

1.2

1.3

24.24

22.30

u/l

0.18

110

742

128

776

1.42

3.54

1.3

1.2

33.37

27.91

u/l

0.38

102

641

Other enthesopathies

122

857

1.43

3.53

1.3

1.2

35.76

23.86

u/l

0.88

104

718

Palmar fascial fibromatosis [Dupuytren]

346

1.68

3.50

1.4

1.3

29.00

27.49

u/l

0.08

278

Other neurological diseases

295

1824

1.26

3.47

1.2

26.07

26.77

u/l

0.08

254

1524

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

138

981

1.39

3.46

1.3

1.2

19.95

21.54

u/l

0.16

116

822

Sleep disorders

365

2048

1.23

3.46

1.2

1.3

25.61

24.72

u/l

0.09

300

1744

Enthesopathies of lower limb, excluding foot

624

1.49

3.43

1.3

23.57

24.64

u/l

0.09

515

Anogenital herpesviral [herpes simplex] infection

100

2.31

3.43

1.3

1.2

11.89

24.99

u/l

0.91

Corneal ulcer

473

1.57

3.41

1.5

1.2

23.63

25.51

u/l

0.15

390

severe traumatic brain injury, does not include concussion

545

1.53

3.39

1.3

1.2

20.75

26.18

u/l

0.85

442

Other disorders of optic [2nd] nerve and visual pathways

127

2.14

3.35

1.3

1.2

35.05

19.16

u/l

1.03

110

Other psoriatic arthropathies

246

1.80

3.35

1.3

1.2

14.47

25.55

u/l

1.22

198

Other inflammation of eyelid, including avohilmo

177

1335

1.33

3.33

1.3

16.44

22.39

u/l

1.48

158

1119

Gonarthrosis

235

1029

1.29

3.33

1.2

1.3

22.48

28.56

u/l

1.12

194

862

Other mental disorders due to brain damage and dysfunction and to physical disease

291

1.72

3.32

1.3

1.2

24.52

26.00

u/l

0.09

239

Fracture at wrist and hand level

132

949

1.39

3.31

1.2

22.18

22.88

u/l

0.05

106

795

Other diseases of upper respiratory tract

441

1910

1.20

3.29

1.3

1.2

23.29

26.97

u/l

0.68

370

1612

Sequelae of cerebrovascular disease

142

884

1.37

3.28

1.2

31.84

28.42

u/l

0.28

112

727

Infections with a predominantly sexual mode of transmission

106

736

1.44

3.26

1.2

26.62

19.43

u/l

0.59

621

Ptosis of eyelid

293

1.71

3.25

1.2

31.20

20.03

u/l

0.62

238

Disorders of optic nerve and visual pathways

205

1.86

3.25

1.2

29.97

24.05

u/l

0.33

177

Bacterial, viral and other infectious agents

163

1.97

3.23

1.3

1.2

29.77

17.83

u/l

0.83

139

Otitis externa

608

1.48

3.23

1.4

1.2

26.66

24.23

u/l

0.14

508

Disease of hard tissues of teeth, NOS

197

783

1.32

3.21

1.2

24.46

25.89

u/l

0.11

162

665

Nonsuppurative otitis media, including avohilmo

110

666

1.43

3.21

1.3

1.2

19.98

20.40

u/l

0.04

561

Other and unspecified effects of external causes

102

708

1.44

3.19

1.3

1.2

28.14

22.01

u/l

0.26

590

Thoracic aortic aneurysm

318

1.67

3.17

1.2

1.3

23.23

21.24

u/l

0.19

259

Traumatic subdural haemorrhage

304

1.67

3.16

1.3

21.77

29.28

u/l

0.99

242

Malignant neoplasm of head and neck

144

2.02

3.14

1.2

56.91

23.60

u/l

0.67

117

Benign thyroid growths and nodules

144

987

1.36

3.14

1.3

1.2

18.83

25.13

u/l

0.87

119

814

Umbilical hernia

662

1.45

3.12

1.3

32.69

25.89

u/l

0.52

552

Ganglion

565

1.49

3.10

1.3

1.2

17.01

23.71

u/l

1.19

470

Epilepsy

119

852

1.39

3.09

1.2

1.3

30.89

25.03

u/l

0.38

716

COPD-related respiratory insufficiency

275

1.72

3.09

1.1

1.3

37.92

27.60

u/l

0.35

226

Sleep apnoea, including avohilmo

402

2023

1.20

3.07

1.2

1.3

19.96

26.78

u/l

2.72

334

1718

Hypopituitarism

139

2.02

3.05

1.4

1.2

40.91

19.97

u/l

1.09

115

Seborrhoeic dermatitis

217

1.80

3.04

1.5

1.2

17.45

24.38

u/l

0.47

175

L02BB Anti-androgens

174

1.90

3.04

2.9

1.2

24.88

33.04

u/l

0.61

141

Synovial cyst of popliteal space [Baker]

167

1.93

3.04

1.5

1.2

20.22

17.49

u/l

0.18

138

Chondropathies

361

1.61

3.03

1.2

29.60

25.18

u/l

0.29

301

Fall on and from stairs and steps

107

759

1.41

3.00

1.3

1.2

36.05

25.33

u/l

0.90

622

Mixed connective tissue disease

3.59

3.00

1.4

1.2

13.36

17.00

u/l

0.31

Rheumatic fever with heart involvement

10.23

2.99

1.6

22.20

21.00

u/l

—

Maternal care for other conditions predominantly related to pregnancy

476

1.52

2.99

1.2

17.22

23.33

u/l

0.74

401

Other crystal arthropathies

3.88

2.98

1.2

1.1

10.10

15.56

u/l

—

Polyarthrosis

564

1.46

2.96

1.2

28.57

23.64

u/l

0.35

469

Complications of labour and delivery

168

1222

0.76

2.96

1.2

17.00

24.11

u/l

1.74

143

1032

Rotator cuff syndrome

234

1278

1.26

2.90

1.3

25.23

26.55

u/l

0.14

197

1078

Carpal tunnel syndrome

250

1738

1.25

2.90

1.3

1.2

18.84

26.01

u/l

2.69

219

1454

Viral warts

206

1.80

2.90

1.4

1.2

16.97

24.84

u/l

0.68

172

Drug-induced osteoporosis

3.76

2.89

1.4

1.3

39.90

16.91

u/l

—

Postpartum haemorrhage

529

0.58

2.89

1.3

1.2

12.66

24.72

u/l

1.61

453

D07AA Corticosteroids, weak (group I)

334

1.62

2.88

1.1

1.2

25.04

25.48

u/l

0.02

279

Hallux rigidus

382

1.58

2.87

1.2

1.3

27.02

22.59

u/l

0.29

311

Other superficial mycoses

3.18

2.85

1.6

1.1

9.33

14.27

u/l

0.81

Dementia

105

998

0.72

2.85

1.2

31.98

28.80

u/l

0.19

825

Problems related to lifestyle

171

1.88

2.85

1.2

32.50

22.20

u/l

0.33

142

Injuries to the wrist and hand

399

2222

1.19

2.83

1.3

26.15

25.54

u/l

0.06

336

1884

Maternal care for known or suspected malpresentation of fetus

278

0.46

2.83

1.5

1.2

18.22

23.69

u/l

0.18

245

Sensorineural hearing loss

213

1786

0.79

2.80

1.3

1.2

27.53

27.49

u/l

0.00

186

1500

Post-traumatic stress disorder

110

2.10

2.78

1.3

1.2

14.33

22.67

u/l

0.44

LSIL lesion of the cervix uteri, vagina or vulva

323

1.61

2.77

1.2

22.64

21.14

u/l

0.05

274

Appendectomy

243

1866

1.24

2.74

1.3

32.15

23.52

u/l

1.10

207

1576

Adhesive capsulitis of shoulder

467

1.50

2.73

1.1

1.2

21.92

23.46

u/l

0.10

382

Sequelae of injuries, of poisoning and of other consequences of external causes

631

1.43

2.73

1.2

20.32

24.20

u/l

0.38

524

Malignant neoplasm of head and neck, including Hilmo

181

1.83

2.72

1.2

55.08

23.81

u/l

0.72

149

Premature rupture of membranes

358

0.54

2.71

1.4

1.2

48.20

23.64

u/l

0.32

317

Pneumococcal septicemia

2.44

2.71

1.5

1.3

23.19

20.18

u/l

0.24

Insomnia

354

2057

1.20

2.71

1.2

1.3

26.29

24.66

u/l

0.17

289

1749

Dementia, including avohilmo

115

1063

0.74

2.68

1.2

1.3

30.80

28.88

u/l

0.11

880

Atopic dermatitis, strict definition with reimbursement

102

705

1.39

2.66

1.2

34.70

18.26

u/l

0.70

597

Follow-up examination after treatment for malignant neoplasms

235

1.71

2.64

1.3

1.2

28.03

25.28

u/l

0.13

195

Pneumonia due to Streptococcus pneumoniae

2.40

2.63

1.5

1.2

19.81

18.16

u/l

0.14

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

712

1.39

2.62

1.2

35.46

20.94

u/l

0.88

601

Cervicalgia

562

1.44

2.61

1.3

1.2

20.85

25.59

u/l

0.55

463

Use of donepezil

568

0.59

2.61

1.1

1.2

26.41

29.63

u/l

0.16

466

Crystal arthropathies, rheuma endpoint

3.36

2.61

1.2

1.1

10.10

15.10

u/l

—

Dental operations

229

941

1.25

2.59

1.2

29.67

26.86

u/l

0.26

182

796

Anogenital herpesviral [herpes simplex] infection, including avohilmo

199

1.76

2.59

1.2

12.62

21.03

u/l

1.06

174

171

1200

1.28

2.57

1.2

29.38

28.51

u/l

0.09

141

991

False labour

479

0.63

2.57

1.2

1.3

8.02

23.60

u/l

4.99

418

Somnolence, stupor and coma

2.20

2.57

1.3

1.2

36.46

21.52

u/l

0.44

Redundant prepuce, phimosis and paraphimosis

434

1.50

2.57

1.5

1.3

29.22

24.70

u/l

0.32

366

Acne

162

1.85

2.57

1.3

1.2

12.67

22.39

u/l

1.00

139

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

623

1.41

2.57

1.2

14.92

22.05

u/l

1.61

528

Malignant neoplasm of colon

338

1.57

2.55

1.1

1.2

47.50

21.35

u/l

1.22

272

Malignant neoplasm of colon, including Hilmo

408

1.52

2.55

1.1

1.2

42.45

22.49

u/l

1.00

338

Spondylolisthesis/Spondylolysis

516

1.46

2.54

1.4

1.2

22.55

24.84

u/l

0.17

423

Colon adenocarcinoma

253

1.66

2.54

1.1

1.2

51.40

20.74

u/l

1.10

203

Other and unspecified follicular disorders

2.23

2.54

1.2

16.55

19.44

u/l

0.20

Aggressive periodontitis

2.62

2.54

1.2

16.08

20.24

u/l

0.22

Benign neoplasm of eye and adnexa

261

1.65

2.53

1.2

46.81

21.74

u/l

0.52

216

Artificial joint re-operation

164

1.84

2.53

1.1

1.2

25.54

22.03

u/l

0.21

138

Dermatophytosis

332

1.57

2.50

1.3

1.2

37.64

23.98

u/l

0.44

269

Nonspecific lymphadenitis

122

1.98

2.50

1.3

1.2

36.61

14.33

u/l

0.58

100

Other and unspecified disorders of vitreous body

184

1425

1.26

2.49

1.3

1.2

19.84

23.80

u/l

0.65

152

1189

Status post-ami

459

1.42

2.49

1.2

1.3

38.24

29.18

u/l

0.54

382

Acute and transient psychotic disorders

270

1.63

2.49

1.1

1.2

15.81

23.02

u/l

0.76

223

Other specified disorders of kidney and ureter

2.34

2.49

1.1

1.2

19.25

18.29

u/l

0.05

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

217

1.71

2.48

1.4

1.2

34.13

19.99

u/l

0.47

178

Nummular dermatitis

180

1.78

2.47

1.6

1.2

27.96

21.79

u/l

0.25

146

Single delivery by caesarean section

316

0.58

2.47

1.2

1.3

10.41

26.64

u/l

2.85

274

Suicide or other Intentional self-harm

611

1.41

2.46

1.2

38.29

22.32

u/l

0.88

511

Disorders of breast

205

1447

1.25

2.46

1.3

1.2

19.53

23.79

u/l

0.52

180

1224

Burns and corrosions

302

1.59

2.46

1.2

23.40

24.52

u/l

0.05

247

Raynaud syndrome

188

1.76

2.44

1.2

72.37

23.42

u/l

0.80

162

Occupational exposure to risk-factors

0.00

2.42

0.0

1.2

—

20.35

—

Non-Hodgkin lymphoma, all

2.30

2.41

1.4

1.2

96.13

22.00

u/l

1.70

Abnormal findings in secretions and smears from cervix uteri vagina vulva

188

1099

1.26

2.40

1.2

21.78

22.59

u/l

0.05

158

937

Infections with a predominantly sexual mode of transmission, including avohilmo

132

920

1.31

2.40

1.2

30.75

19.86

u/l

0.75

108

784

Other headache syndromes

163

1279

1.27

2.35

1.3

20.93

24.73

u/l

0.35

136

1088

Dislocation, sprain and strain of joints and ligaments of thorax

2.27

2.34

1.3

1.2

31.06

19.27

u/l

0.48

Other and unspecified myopathies

191

1.73

2.33

1.2

22.07

19.41

u/l

0.24

157

Missing teeth due to accident, extraction or parodontitis

251

1852

1.21

2.30

1.2

1.3

27.68

25.69

u/l

0.21

208

1558

Unspecified mental disorder

143

1113

1.29

2.27

1.1

1.3

17.45

22.74

u/l

0.92

122

933

Dermatographic urticaria

134

1.87

2.26

1.5

1.2

12.74

26.04

u/l

1.07

115

Cerebral cysts

106

1.99

2.25

1.2

33.14

20.27

u/l

0.51

Plantar fascial fibromatosis

263

1.60

2.23

1.2

18.00

19.18

u/l

0.09

224

Migraine with aura

657

1.37

2.22

1.4

1.2

22.55

23.63

u/l

0.07

556

Ovarian cyst

142

628

1.29

2.20

1.3

1.2

21.58

24.62

u/l

0.41

117

526

Granulomatous disorders of skin and subcutaneous tissue

2.52

2.19

1.7

1.1

25.00

16.17

u/l

0.30

Nontoxic diffuse goitre

2.25

2.18

1.2

1.1

9.10

14.25

u/l

—

Use of memantine

660

0.68

2.17

1.1

1.2

34.14

30.82

u/l

0.17

542

Use of other anti-dementia drugs

660

0.68

2.17

1.1

1.2

34.14

30.82

u/l

0.17

542

Other disorders of nervous system

151

1.80

2.16

1.6

1.2

17.45

22.32

u/l

0.50

127

Foreign body in alimentary tract

108

1.95

2.15

1.2

23.60

20.84

u/l

0.14

593

1.37

2.14

1.3

1.2

27.18

28.02

u/l

0.05

484

Wide developmental disorders, excluding more controls

2.80

2.14

1.5

1.1

8.50

11.33

u/l

—

Assault

258

1.59

2.14

1.3

1.2

37.31

22.47

u/l

0.70

217

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

370

1.49

2.14

1.2

34.60

24.00

u/l

0.37

311

Abdominal aortic aneurysm (AAA)

180

1.71

2.12

1.3

1.2

45.00

32.26

u/l

0.48

148

LSIL lesion of the cervix uteri

228

1.63

2.10

1.2

11.69

24.88

u/l

1.49

199

Atopic dermatitis, strict definition

701

1.34

2.07

1.2

35.44

18.99

u/l

0.66

598

Other abnormal products of conception

557

0.69

2.06

1.3

1.2

11.83

22.05

u/l

2.48

470

Mixed conductive and sensorineural hearing loss

333

1.51

2.05

1.3

1.2

31.76

23.27

u/l

0.36

274

Other and unspecified haemorrhagic conditions

3.10

2.02

1.4

1.3

42.88

15.05

u/l

—

Spontaneous rupture of synovium and tendon

200

1.66

2.01

1.1

1.2

34.93

21.76

u/l

0.44

169

Postpartum hemorraghe, all women as controls

563

0.64

2.00

1.3

1.2

12.66

22.03

u/l

1.18

484

Autism spe

2.83

2.00

1.6

1.2

8.89

10.12

u/l

—

Autism

2.82

2.00

1.6

1.3

8.89

9.42

u/l

—

Cervicocranial syndrome

263

1.56

2.00

1.6

1.2

36.44

25.37

u/l

0.32

213

Disorders of muscles

224

1.61

1.99

1.4

1.2

15.94

22.59

u/l

0.70

185

Transient ischemic attack

201

1317

1.22

1.96

1.2

28.38

26.12

u/l

0.20

168

1098

Benign neoplasm of breast

337

1.49

1.96

1.2

17.73

21.13

u/l

0.42

276

Spirochaetal infections, other/unspecified

202

1.64

1.95

1.2

17.48

21.19

u/l

0.38

168

Injury of eye and orbit

289

1.53

1.94

1.2

27.06

21.79

u/l

0.39

242

Portal vein thrombosis

2.75

1.93

1.6

1.2

33.44

18.48

u/l

—

Actinic keratosis

153

1116

1.25

1.93

1.3

1.2

31.17

29.07

u/l

0.21

125

921

Maternal care related to the fetus and amniotic cavity and possible delivery problems

109

828

0.77

1.92

1.2

20.58

22.55

u/l

0.09

714

Scabies, including avohilmo

306

1.51

1.91

1.2

13.03

21.20

u/l

1.32

261

Diseases of external ear

133

1053

1.26

1.91

1.3

1.2

24.45

24.75

u/l

0.02

112

866

Skin changes due to chronic exposure to nonionizing radiation

157

1146

1.24

1.90

1.2

31.03

29.07

u/l

0.20

128

947

Adult respiratory distress syndrome

3.21

1.88

1.0

1.2

80.86

19.35

u/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

212

1.61

1.88

1.3

1.2

23.03

19.16

u/l

0.33

172

Superficial injury of shoulder and upper arm

276

1.53

1.86

1.3

1.2

32.92

25.72

u/l

0.23

231

Other and unspecified nerve root and plexus disorders, also in other diseases

590

0.66

1.86

1.2

20.65

23.79

u/l

0.18

483

Superficial injury of wrist and hand

508

1.38

1.86

1.2

19.82

21.71

u/l

0.14

432

Foreign body entering into or through eye or natural orifice

159

1.70

1.85

1.7

1.2

18.64

20.74

u/l

0.14

131

Other and unspecified rosacea

221

1.59

1.84

1.3

1.2

12.83

19.98

u/l

1.26

182

Contact with sharp glass

2.21

1.84

1.3

1.2

16.08

16.33

u/l

0.02

Otitis externa, unspecified

245

1.55

1.83

1.2

22.76

22.48

u/l

0.02

207

Other disorders of the genitourinary system

392

1.43

1.83

1.3

1.2

14.88

26.26

u/l

1.15

323

Other hammer toe(s) (acquired)

463

1.38

1.82

1.1

1.2

29.00

23.44

u/l

0.49

383

Cysts of oral region, not elsewhere classified

108

1.86

1.81

1.3

1.2

32.80

18.40

u/l

0.72

Conductive and sensorineural hearing loss

236

1854

0.84

1.81

1.3

1.2

29.79

27.21

u/l

0.20

206

1560

Other specified congenital malformation syndromes affecting multiple systems

3.06

1.80

1.3

10.14

12.89

u/l

—

Clear cell adenocarcinoma of kidney

1.96

1.80

1.4

1.1

36.33

20.17

u/l

0.49

Graves disease, strict definition

247

1.54

1.78

1.2

14.03

25.79

u/l

1.14

210

Toxic effect of ethanol

2.18

1.78

1.0

1.2

78.33

15.61

u/l

—

Necrosis of pulp, including avohilmo

207

1711

1.20

1.77

1.2

1.3

21.78

24.58

u/l

0.41

174

1446

Benign neoplasm of urinary organs

102

1.87

1.76

1.5

1.2

18.26

18.85

u/l

0.04

Restless leg syndrome

387

1.42

1.76

1.1

1.2

12.91

25.85

u/l

2.39

323

Alzheimer disease, including avohilmo

829

0.77

1.75

1.1

1.2

28.66

30.57

u/l

0.13

692

Mouth breathing

138

1109

1.24

1.75

1.2

1.3

27.10

24.64

u/l

0.18

116

931

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.23

1.73

1.3

1.2

9.92

13.63

u/l

0.61

Lagophthalmos

2.94

1.73

1.4

1.3

26.14

27.26

u/l

—

Other congenital malformations of skin, including avohilmo

178

1.63

1.72

1.2

14.78

20.85

u/l

0.52

152

Oter anti-inflammatory and antirheumatic agents, non-steroids

326

1.35

1.71

1.2

23.12

30.10

u/l

0.47

284

Benign neoplasm of male genital organs

0.00

1.71

0.0

1.2

—

21.22

—

Dental pulpitis, including avohilmo

331

1841

1.15

1.70

1.2

1.3

19.53

24.89

u/l

1.54

269

1564

Deficiency of other B group vitamins

2.52

1.67

1.3

1.2

19.30

20.24

u/l

—

Acne, including avohilmo

315

1.41

1.66

1.2

1.3

14.23

18.85

u/l

0.59

276

Other and unspecified tonsillitis

566

1.31

1.66

1.2

28.62

23.44

u/l

0.32

475

Colorectal cancer

539

1.34

1.65

1.2

37.64

22.62

u/l

0.88

445

Diplopia

301

1.47

1.64

1.4

1.2

30.25

24.78

u/l

0.17

247

Acute suppurative otitis media

500

1.34

1.64

1.4

1.2

25.40

17.87

u/l

0.32

424

Myocardial infarction, unclassifiable

479

1.34

1.64

1.3

1.2

43.68

31.77

u/l

0.61

394

Periapical abscess

169

1401

1.21

1.63

1.3

24.08

24.59

u/l

0.04

142

1172

Nonsuppurative otitis media

407

1.37

1.61

1.4

1.2

22.55

21.91

u/l

0.04

342

Disorders of psychological development

190

1.56

1.60

1.3

1.2

15.73

19.50

u/l

0.26

171

Female genital prolapse

577

0.76

1.60

1.2

15.28

25.60

u/l

2.34

479

Peroneal tendinitis

2.71

1.58

1.1

1.2

13.14

12.00

u/l

—

Use of rivastigmine

423

0.64

1.58

1.1

1.2

17.19

30.37

u/l

1.40

343

Other and unspecified acute skin changes due to ultraviolet radiation

2.21

1.57

1.2

16.27

19.88

u/l

0.29

Other fall from one level to another

524

1.34

1.57

1.4

1.2

17.73

25.42

u/l

1.36

434

Disorders of ocular muscles, binocular movement, accommodation and refraction

167

1378

1.20

1.55

1.3

30.70

22.82

u/l

0.59

141

1149

Carcinoma in situ of breast, intraductal

264

1.48

1.55

1.3

1.2

10.42

24.37

u/l

2.26

219

Paracetamol or NSAID medication

163

1.46

1.54

1.2

16.15

17.94

u/l

0.22

143

Retinal breaks without detachment

449

1.36

1.54

1.4

1.2

18.72

24.81

u/l

0.72

372

Alzheimer disease

718

0.77

1.53

1.1

1.2

27.44

30.80

u/l

0.24

597

Other and unspecified nonorganic psychotic disorders

441

1.36

1.53

1.1

1.2

11.16

23.10

u/l

2.82

376

Other meningitis

2.61

1.51

1.0

1.3

22.29

16.91

u/l

—

Colorectal cancer, including Hilmo

597

1.30

1.51

1.2

35.88

23.25

u/l

0.79

495

Aortic valve malfunction, age under 60 years

201

1.55

1.51

1.3

1.2

22.85

19.44

u/l

0.25

163

Schizophrenia or delusion, excluding more controls

729

1.27

1.50

1.1

1.3

13.20

23.34

u/l

3.53

618

Migraine with aura and triptan purchases

383

1.39

1.50

1.4

1.2

18.93

22.24

u/l

0.30

328

Pediculosis, acariasis and other infestations, including avohilmo

375

1.39

1.49

1.2

14.14

21.38

u/l

1.22

318

Meniscus derangement

184

1026

1.19

1.48

1.2

1.3

20.68

28.40

u/l

1.83

158

859

COPD, hospital admissions 1, only main diagnosis

121

843

1.23

1.46

1.2

1.3

34.45

29.54

u/l

0.30

686

Suggestive for eosinophilic asthma

211

1.52

1.45

1.3

1.2

18.17

19.82

u/l

0.13

169

Intracranial and intraspinal abscess and granuloma

2.75

1.44

1.5

1.2

51.33

17.71

u/l

—

Attention to artificial openings

1.93

1.44

1.6

1.2

34.71

21.89

u/l

0.66

Persons encountering health services in other circumstances

129

1046

1.22

1.43

1.3

1.2

28.67

23.31

u/l

0.64

113

859

Polypectomy (DHB20)

133

1.66

1.42

1.4

1.2

28.63

23.17

u/l

0.35

110

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

212

1410

1.17

1.41

1.2

1.3

22.51

23.12

u/l

0.04

180

1189

Abnormal involuntary movements

346

1.39

1.40

1.4

1.2

14.88

25.12

u/l

1.36

290

Other articular cartilage disorders

2.42

1.39

1.0

1.1

14.14

16.83

u/l

—

Benign neoplasm: Kidney

1.90

1.39

1.4

1.2

13.93

17.77

u/l

0.43

Abrasion of teeth

138

1144

1.21

1.39

1.2

1.3

26.95

21.12

u/l

0.36

114

954

Recurrent dislocation of patella

2.08

1.38

1.2

1.1

18.36

32.67

u/l

0.42

Acute epiglottitis

2.62

1.37

1.2

1.3

48.17

9.88

u/l

—

Strabismus

695

1.26

1.35

1.3

1.2

30.57

23.55

u/l

0.48

576

Other bursopathies

340

1.39

1.35

1.4

1.2

20.43

24.89

u/l

0.37

277

Postpartum hemorraghe, parous women as controls

440

0.70

1.34

1.3

1.2

12.66

17.99

u/l

0.59

377

Excessive earwax

181

1918

0.85

1.33

1.2

24.58

26.22

u/l

0.19

153

1609

Excessive attrition of teeth

213

1820

1.16

1.33

1.3

31.61

22.91

u/l

0.63

178

1536

Toxic effects of substances chiefly nonmedicinal as to source

224

1.48

1.33

1.1

1.2

45.25

25.25

u/l

0.40

186

Vulvovaginal ulceration/inflammation in other diseases

128

1.64

1.33

1.1

12.00

20.26

u/l

0.86

109

Other problems related to primary support group, including family circumstances

194

1.51

1.32

1.1

1.2

21.00

20.41

u/l

0.03

164

Hyperplasia of prostate

103

465

1.25

1.32

1.3

49.63

31.46

u/l

1.07

394

Alcohol withdrawal state with delirium

144

1.60

1.32

1.1

1.2

50.94

24.78

u/l

0.45

118

Suppurative otitis media, unspecified

0.00

1.31

0.0

1.3

—

21.45

—

Striking against or struck by other objects

103

833

1.24

1.31

1.3

32.72

22.53

u/l

0.75

704

Benign neoplasm: Brain, supratentorial

2.51

1.30

1.0

1.3

11.17

18.05

u/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

121

1.66

1.30

1.1

1.2

16.80

25.57

u/l

0.54

102

Hallux valgus (acquired)

120

704

1.22

1.30

1.2

18.10

23.56

u/l

1.06

107

590

Wet age-related macular degeneration

463

1.31

1.30

1.4

1.2

44.90

29.99

u/l

0.65

375

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

135

0.44

1.27

1.7

1.2

6.33

33.23

u/l

—

115

Congenital malformations of the circulatory system

301

1.39

1.27

1.5

1.2

24.97

24.07

u/l

0.05

249

Acute nasopharyngitis (common cold)

233

1.45

1.26

1.3

1.2

15.48

25.41

u/l

0.99

190

Other hearing loss

112

892

1.22

1.25

1.2

23.83

28.48

u/l

0.52

734

Kela-code for severe mental illness

119

985

1.21

1.24

1.1

1.3

18.07

23.39

u/l

0.75

102

826

Acute nephritic syndrome

2.01

1.23

1.4

1.1

32.22

18.14

u/l

—

Childhood allergy (age < 16)

167

1.48

1.22

1.2

1.3

16.00

17.95

u/l

0.09

153

Wide developmental disorders

2.04

1.20

1.5

1.2

8.50

13.37

u/l

—

Colorectal adenocarcinoma

446

1.31

1.20

1.2

41.34

23.17

u/l

0.84

366

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.84

1.19

1.3

1.2

71.77

14.66

u/l

0.80

Focal epilepsy

541

1.28

1.18

1.2

29.79

25.30

u/l

0.21

449

Seborrhoeic keratosis

747

1.23

1.18

1.4

1.2

24.39

24.92

u/l

0.04

616

Degenerative diseases of the nervous system

820

0.81

1.17

1.2

29.61

29.71

u/l

0.01

678

Cervical disc disorders

122

1021

1.20

1.16

1.3

20.43

25.76

u/l

0.55

103

848

Allergic contact dermatitis due to drugs in contact with skin

2.06

1.15

1.4

1.2

24.63

17.31

u/l

—

Early syphilis

2.52

1.15

1.0

1.3

49.20

21.14

u/l

—

Other disorders of bladder

232

1.42

1.14

1.3

1.2

16.39

22.90

u/l

0.84

189

Presence of other functional implants

209

1247

1.15

1.14

1.3

1.2

26.99

24.42

u/l

0.32

181

1031

Other infestations, including avohilmo

0.00

1.14

0.0

1.2

—

13.90

—

Car occupant injured in other and unspecified transport accidents

431

1.30

1.12

1.3

1.2

49.78

23.65

u/l

0.57

367

Special screening examination for neoplasms

135

1.56

1.11

2.0

1.2

36.25

22.91

u/l

0.44

119

Herpesviral [herpes simplex] infections, including avohilmo

708

1.23

1.11

1.2

25.15

22.33

u/l

0.20

590

Benign neoplasm: Other and unspecified parts of small intestine

2.27

1.10

1.0

1.2

10.57

26.96

u/l

—

Optic atrophy, wide definition

2.27

1.10

1.3

57.71

16.85

u/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

781

1.22

1.10

1.3

1.2

21.65

21.30

u/l

0.03

660

Whooping cough, including avohilmo

2.39

1.09

1.8

1.1

18.80

10.00

u/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

180

1508

1.15

1.09

1.2

20.92

26.74

u/l

0.94

156

1258

Procedures for purposes other than remedying health state

1.96

1.09

1.1

1.2

20.50

13.29

u/l

—

Unspecified event, undetermined intent

1.96

1.09

1.1

1.3

10.25

15.44

u/l

—

Alcohol abuse, main dg, excluding more controls

303

1.36

1.08

1.1

1.3

46.79

24.99

u/l

0.70

257

Combinations of oral blood glucose lowering drugs

783

1.21

1.08

1.3

42.04

23.42

u/l

1.31

641

Other strabismus

538

1.26

1.07

1.4

1.2

18.92

22.32

u/l

0.32

451

Labour and delivery complicated by fetal stress [distress]

313

0.73

1.07

1.3

15.03

25.09

u/l

0.91

269

Inflammatory diseases of female pelvic organs

240

1453

1.13

1.07

1.3

1.2

21.56

23.07

u/l

0.14

200

1240

Leiomyoma of uterus

251

1247

1.13

1.07

1.3

1.2

19.44

24.65

u/l

1.01

214

1053

Rosacea

330

1.34

1.06

1.4

1.2

14.43

23.99

u/l

1.31

279

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.93

1.06

1.1

1.2

31.80

23.20

u/l

—

Colon adenocarcinoma, helper endpoint

313

1.34

1.06

1.1

1.2

51.40

27.33

u/l

0.77

255

Torsion of ovary, ovarian pedicle and fallopian tube

2.13

1.05

1.1

12.43

12.85

u/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

480

1.27

1.05

1.1

1.2

13.00

20.13

u/l

1.31

406

Speech and linguistic disorders, excluding more controls

114

1.57

1.02

1.3

1.2

22.00

22.04

u/l

0.00

103

Paralytic strabismus

147

1.50

1.00

1.3

1.2

69.53

20.35

u/l

1.20

120

Other symptoms and signs involving the urinary system

231

1.39

0.99

1.3

1.2

30.81

21.13

u/l

0.75

194

Early syphilis, including avohilmo

2.18

0.98

1.0

1.2

49.20

19.18

u/l

—

Shoulder region

2.18

0.98

1.8

1.3

11.60

18.17

u/l

—

Other sleep disorders

283

1.35

0.98

1.2

19.55

26.32

u/l

0.46

239

Laparoscopic left hemicolectomy

1.95

0.97

1.1

11.00

20.53

u/l

—

Fistulae involving female genital tract

1.95

0.97

1.1

1.2

6.00

13.30

u/l

—

Congenital malformations of heart and great arteries

258

1.36

0.97

1.4

1.2

36.50

23.17

u/l

0.57

216

Chronic iridocyclitis

100

1.60

0.96

1.1

1.2

14.50

18.48

u/l

0.53

Migraine without aura

495

1.25

0.96

1.2

19.19

22.10

u/l

0.15

424

Internal derangement of knee

112

940

1.18

0.96

1.2

1.3

27.29

26.75

u/l

0.02

779

Superficial injury of ankle and foot

267

1.35

0.95

1.4

1.2

19.13

21.49

u/l

0.15

225

Use of antiglaucoma preparations and miotics

183

1.42

0.93

1.2

22.19

20.96

u/l

0.13

145

Cluster headache, strict

1.72

0.92

1.5

1.1

6.42

17.53

u/l

3.96

Other disorders of breast

392

1.28

0.91

1.3

1.2

26.72

24.34

u/l

0.07

328

Diseases of middle ear and mastoid

181

1304

1.13

0.90

1.3

1.2

28.83

22.61

u/l

0.42

165

1084

Carcinoma in situ of breast, other/unspecified

2.08

0.89

1.5

1.2

6.67

16.52

u/l

—

Optic atrophy

2.08

0.89

1.3

64.50

16.08

u/l

—

Malignant neoplasm of tonsil and base of tongue

2.08

0.89

1.0

1.1

16.00

23.73

u/l

—

Focal brain injury

135

1.48

0.89

1.1

1.3

27.64

21.12

u/l

0.26

105

Diseases of the ear and mastoid process

420

1937

1.09

0.88

1.3

1.2

26.76

25.70

u/l

0.09

353

1635

Other maternal disorders predominantly related to pregnancy

163

1159

0.88

0.87

1.3

1.2

17.71

22.87

u/l

1.24

148

975

Hypersensitivity pneumonitis due to organic dust

2.01

0.87

1.2

1.3

17.50

16.84

u/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

354

1.23

0.87

1.3

1.2

21.77

22.17

u/l

0.01

313

Diseases of inner ear

202

1726

1.12

0.86

1.2

22.10

25.34

u/l

0.49

170

1436

Effects of foreign body entering through natural orifice

576

1.22

0.86

1.3

20.57

24.19

u/l

0.34

477

Obstructed labour due to malposition and malpresentation of fetus

539

0.79

0.85

1.2

12.95

24.99

u/l

2.37

458

Open wound of wrist and hand

138

1163

1.15

0.85

1.3

39.44

23.88

u/l

1.08

114

979

Long labour

531

0.80

0.85

1.4

1.2

24.83

23.51

u/l

0.07

450

Type of accident

834

0.83

0.84

1.3

1.2

39.97

23.65

u/l

1.10

687

Motorcycle rider injured in other and unspecified transport accidents

104

1.54

0.84

1.0

1.2

15.64

15.78

u/l

0.01

Other bullous disorders

1.76

0.83

1.3

1.2

19.80

16.28

u/l

—

Certain zoonotic bacterial diseases, including avohilmo

1.76

0.83

1.0

1.2

21.90

18.45

u/l

—

Other extrapyramidal and movement disorders in other diseases

743

1.19

0.83

1.3

1.2

18.96

25.85

u/l

0.98

610

Melanocytic naevi of other and unspecified parts of face

129

1.48

0.83

1.5

1.2

20.36

23.90

u/l

0.19

110

Fitting and adjustment of other devices

877

0.84

0.83

1.2

26.25

24.55

u/l

0.17

715

Spontaneous abortion

128

985

0.87

0.83

1.3

1.2

13.48

22.57

u/l

3.65

118

827

Suppurative and unspecified otitis media

100

755

1.17

0.83

1.4

1.2

30.73

20.06

u/l

0.44

631

Iridocyclitis in diseases classified elsewhere

1.88

0.82

1.2

64.50

15.83

u/l

—

Intussusception

1.88

0.82

1.2

17.50

16.08

u/l

—

Contact with and exposure to communicable diseases

674

0.81

1.3

1.2

47.39

19.20

u/l

0.61

575

All dysplastic lesions of the cervix uteri, vagina or vulva

727

1.18

0.80

1.2

29.80

20.37

u/l

0.41

611

Glucosamine medication

147

1330

0.88

0.80

1.2

19.16

27.13

u/l

1.44

116

1105

Alzheimer’s disease (Late onset)

575

0.81

0.80

1.1

1.2

31.33

31.72

u/l

0.02

476

Heartburn

276

1.31

0.80

1.3

1.2

21.81

23.34

u/l

0.07

222

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.82

0.79

1.0

1.1

16.00

21.64

u/l

—

Glaucoma

213

1630

1.11

0.78

1.2

22.48

27.05

u/l

0.94

177

1356

Artrosis, including avohilmo

290

1449

1.10

0.78

1.2

1.3

25.28

27.79

u/l

0.25

243

1230

Leisure time condition

473

0.78

0.77

1.3

1.2

24.25

26.30

u/l

0.15

390

Lichen planus

367

1.26

0.76

1.3

1.2

26.25

23.80

u/l

0.12

299

Burn and corrosion of hip and lower limb, except ankle and foot

1.77

0.76

1.2

19.17

16.00

u/l

—

Coxibs

400

1.18

0.76

1.1

1.2

18.19

27.05

u/l

1.88

356

Any dementia

112

891

0.87

0.76

1.2

33.13

29.56

u/l

0.23

745

Benign paroxysmal vertigo

109

946

1.15

0.75

1.3

1.2

23.27

25.13

u/l

0.15

785

Tonsillectomy and adenotomy

133

1051

0.88

0.75

1.3

1.2

24.52

20.06

u/l

0.28

115

895

Nasal polyp

495

1.21

0.74

1.3

1.2

20.42

22.92

u/l

0.28

406

Adenocarcinoma of pancreas

1.85

0.73

1.3

1.1

23.57

24.69

u/l

—

Inflammatory disease of uterus

335

1.26

0.71

1.2

19.97

21.62

u/l

0.09

287

Medical abortion

238

1172

1.10

0.71

1.3

1.2

28.49

23.50

u/l

0.48

205

983

Focal epilepsy, strict definition

498

1.21

0.71

1.2

31.87

25.74

u/l

0.27

409

Other obstetric conditions, not elsewhere classified

370

1.19

0.71

1.3

21.43

22.26

u/l

0.02

326

Noninflammatory disorders of female genital tract

112

644

0.87

0.70

1.2

1.3

27.59

24.29

u/l

0.15

538

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

804

0.85

0.69

1.3

1.2

18.62

23.81

u/l

0.75

664

Presbycusis

395

1.23

0.68

1.1

1.2

26.69

30.61

u/l

0.26

319

Other noninflammatory disorders of vulva and perineum

284

1.27

0.68

1.2

31.97

25.37

u/l

0.17

233

Keratoconus

1.63

0.67

1.1

1.2

56.71

15.03

u/l

—

Disorders of vestibular function (Vertigo)

174

1531

1.11

0.66

1.2

23.64

24.72

u/l

0.11

146

1269

Infective dermatitis

259

1.28

0.65

1.2

24.50

22.76

u/l

0.09

216

Pathological resorption of teeth

1.58

0.65

1.3

1.2

22.45

17.72

u/l

0.28

Other disorders of penis

206

1.31

0.64

1.4

1.3

51.10

22.99

u/l

0.65

167

Pollen allergy

398

1.21

0.64

1.2

12.87

20.52

u/l

1.21

343

malignant neoplasm of female genital organs, including Hilmo

463

1.19

0.64

1.3

1.2

27.72

21.02

u/l

0.53

384

Abnormal findings on diagnostic imaging of breast

1.73

0.64

1.0

1.2

14.00

17.46

u/l

—

Pyogenic granuloma

1.73

0.64

1.4

1.2

14.80

15.71

u/l

—

Lyme disease

119

1056

1.13

0.63

1.2

1.3

16.23

23.35

u/l

2.22

872

Lyme disease, including avohilmo

119

1056

1.13

0.63

1.2

1.3

16.23

23.35

u/l

2.22

872

Acute appendicitis, no complications

177

1596

1.10

0.63

1.2

1.3

23.03

25.27

u/l

0.28

148

1341

Other disorders of conjunctiva

369

1.22

0.62

1.4

1.2

36.32

22.54

u/l

0.29

302

Other spirochaetal diseases

120

1067

1.13

0.62

1.2

1.3

16.75

23.19

u/l

1.87

882

Alcohol abuse, main dg

333

1.23

0.62

1.1

1.2

46.79

25.42

u/l

0.69

272

Blepharochalasis

975

0.87

0.61

1.3

1.2

25.84

23.10

u/l

0.16

808

Alopecia areata

1.60

0.61

1.1

1.2

16.50

17.45

u/l

—

Uterine polyps

113

583

1.13

0.61

1.2

20.36

25.63

u/l

0.47

484

Salpingitis and oophoritis

554

1.17

0.60

1.5

1.2

26.30

22.58

u/l

0.12

459

Alzheimer’s disease, strict definition

614

0.85

0.60

1.1

1.2

27.86

31.62

u/l

0.23

507

Lichen planus, including avohilmo

582

1.17

0.60

1.2

34.38

25.61

u/l

0.45

479

Spirochaetal infections, other/unspecified, including avohilmo

119

1060

1.12

0.60

1.2

1.3

16.23

23.28

u/l

2.19

875

Major anomalies of jaw size

1.57

0.60

1.0

1.2

11.75

13.55

u/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

888

0.87

0.60

1.2

40.42

23.24

u/l

1.24

734

Polyp of the female genital tract

117

587

1.13

0.60

1.2

22.24

25.61

u/l

0.27

101

487

Injuries to the neck

566

1.17

0.58

1.3

1.2

21.92

23.90

u/l

0.11

474

Additional codes for the location of defect, injury or illness

123

1.38

0.57

1.4

1.2

13.71

18.07

u/l

0.62

106

Burns and corrosions of multiple and unspecified body regions

1.72

0.57

1.2

1.1

22.50

15.86

u/l

—

All dysplastic lesions of the cervix uteri

603

1.16

0.57

1.2

24.40

20.40

u/l

0.14

512

Coxarthrosis, primary

225

1723

1.08

0.57

1.3

1.2

28.50

25.66

u/l

0.25

189

1437

Tuberculosis of other organs

1.67

0.56

1.5

1.2

36.17

20.00

u/l

—

Migraine

170

1206

1.10

0.55

1.3

21.15

23.18

u/l

0.22

140

1029

Postmenopausal atrophic vaginitis

114

553

1.12

0.55

1.2

19.66

25.56

u/l

0.57

461

Schizophrenia, schizotypal and delusional disorders

841

1.13

0.55

1.1

1.2

14.44

22.75

u/l

2.39

708

Focal epilepsy, mode (most common among epilepsy diagnosis)

458

1.18

0.55

1.3

1.2

31.35

26.82

u/l

0.17

374

Drug-induced adrenocortical insufficiency

1.58

0.54

1.2

1.3

20.00

17.63

u/l

—

Oxicams

354

1.16

0.53

1.1

1.2

25.53

29.39

u/l

0.20

312

Speech and linguistic disorders

145

1.32

0.53

1.4

1.2

21.00

19.85

u/l

0.05

130

Other spirochaetal diseases, including avohilmo

120

1081

1.11

0.52

1.2

1.3

16.75

22.96

u/l

1.78

895

Psoriasis (vulgaris), strict definition

1.52

0.52

1.2

1.1

20.70

18.93

u/l

—

Achilles tendinitis

268

1.23

0.52

1.2

16.91

22.23

u/l

0.42

217

Superficial injury of forearm

205

1.27

0.52

1.2

22.00

26.02

u/l

0.23

165

Primary gonarthrosis, bilateral

200

1545

1.08

0.52

1.2

1.3

26.60

25.84

u/l

0.07

161

1294

Respiratory conditions due to other external agents

1.50

0.51

1.5

1.2

19.50

17.21

u/l

—

Antenatal screening

336

0.85

0.51

1.3

8.62

20.97

u/l

3.66

297

Impacted cerumen

278

1.22

0.51

1.1

1.2

17.61

23.81

u/l

0.63

229

Obstructed labour due to maternal pelvic abnormality

499

0.84

0.50

1.4

1.2

14.70

22.94

u/l

1.14

418

Schizophrenia or delusion

838

1.12

0.50

1.1

1.2

13.20

22.94

u/l

3.68

704

Dentofacial anomalies [including malocclusion]

213

1794

0.93

0.49

1.3

25.21

23.35

u/l

0.19

176

1533

Benign neoplasm: Conjunctiva

1.50

0.49

1.5

1.2

25.90

16.71

u/l

—

Bell's palsy

289

1.21

0.48

1.2

15.55

28.89

u/l

1.69

237

Benign lipomatous neoplasm

891

0.89

0.48

1.2

15.08

24.94

u/l

3.19

727

Tooth agenesis EXCLUDE clefts and syndromes

1.52

0.48

1.1

1.2

38.14

33.13

u/l

—

Benign mammary dysplasia

437

1.17

0.48

1.3

1.2

13.60

26.70

u/l

2.85

360

Injury of muscle and tendon at hip and thigh level

226

1.24

0.48

1.1

1.2

19.86

21.98

u/l

0.11

187

Polycystic ovarian syndrome, broad definition

166

0.72

0.47

1.3

1.2

21.42

19.01

u/l

0.10

142

Acute alcohol intoxication

606

1.14

0.47

1.1

1.3

37.84

26.19

u/l

0.56

505

Deviated nasal septum

879

1.11

0.47

1.4

1.2

30.51

26.56

u/l

0.22

733

Vertical strabismus

1.47

0.47

1.3

1.2

10.40

15.90

u/l

—

Other conjunctival vascular disorders and cysts

1.46

0.47

1.1

1.2

14.57

17.05

u/l

—

Secondary polycythaemia

1.46

0.47

1.0

1.2

12.29

14.97

u/l

—

Propionic acid derivatives

417

0.88

0.46

1.2

33.07

26.44

u/l

0.34

372

Diseases of male genital organs

133

609

1.10

0.46

1.3

31.12

28.13

u/l

0.21

111

521

Injury of muscle and tendon at shoulder and upper arm level

1046

0.90

0.46

1.2

1.3

35.08

25.49

u/l

0.57

856

Other peripheral vertigo

227

1.24

0.46

1.2

19.38

21.84

u/l

0.16

189

Primary open-angle glaucoma

985

0.90

0.46

1.2

28.17

28.85

u/l

0.05

816

Exposure to other and unspecified animate mechanical forces

1.43

0.46

1.1

1.2

44.29

16.53

u/l

—

Cluster headache, strict, including avohilmo

1.39

0.46

1.5

1.1

6.62

17.17

u/l

5.33

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

441

1.16

0.44

1.3

1.2

29.93

19.41

u/l

0.27

376

Any dementia, excluding more controls

102

774

0.90

0.44

1.2

1.3

33.20

29.58

u/l

0.21

650

Juvenile osteochondrosis

1.37

0.44

1.4

1.2

10.86

14.36

u/l

—

Persons encountering health services in circumstances related to reproduction

193

1202

1.08

0.44

1.3

24.79

22.48

u/l

0.16

164

1028

Nontoxic goitre/thyroid nodule

108

981

1.10

0.43

1.2

13.93

24.64

u/l

3.13

814

Use of galantamine

174

0.75

0.43

1.2

1.3

27.15

27.37

u/l

0.01

143

Injury of muscle and tendon at lower leg level

349

1.18

0.43

1.6

1.2

29.50

25.98

u/l

0.17

286

Outcome of delivery

236

1.17

0.42

1.2

1.3

13.23

21.24

u/l

1.00

208

Hypothermia

1.57

0.42

1.2

1.3

19.60

16.00

u/l

—

Subarachnoid haemorrhage

251

0.80

0.42

1.2

20.40

21.43

u/l

0.09

205

Cerebral aneurysm, nonruptured

212

1.23

0.42

1.3

1.2

14.45

20.96

u/l

0.77

180

Spermatocele

149

1.28

0.41

1.1

1.3

32.62

24.07

u/l

0.21

117

Superficial injury of thorax

369

1.17

0.41

1.2

28.31

24.31

u/l

0.22

301

Female infertility, cervical, vaginal, other or unspecified origin

500

1.11

0.41

1.2

1.3

27.31

25.22

u/l

0.08

419

Muscle strain

1.36

0.41

1.5

1.2

7.75

19.66

u/l

—

Glaucoma-related operations

132

1.29

0.40

1.1

1.2

32.30

19.66

u/l

—

110

Oligomenorrhoea

1.31

0.39

1.4

1.2

21.88

15.47

u/l

—

Other specified/unspecified soft tissue disorders

1.34

0.39

1.5

1.2

61.38

19.68

u/l

0.65

Bicipital tendinitis

105

0.67

0.39

1.1

1.2

34.14

18.58

u/l

—

Extrapyramidal and movement disorders

132

1219

1.08

0.39

1.3

23.46

25.67

u/l

0.18

110

1009

Gestational [pregnancy-induced] hypertension

632

0.88

0.38

1.1

1.2

11.26

22.48

u/l

3.24

530

Gestational diabetes (for exclusion)

580

1.10

0.38

1.3

1.2

14.65

21.92

u/l

1.31

495

Viral meningitis, including avohilmo

1.37

0.38

1.2

93.00

16.82

u/l

—

Cervical polyps

323

0.83

0.38

1.1

1.2

33.95

24.07

u/l

0.42

263

Chronic diseases of tonsils and adenoids

238

1590

0.94

0.38

1.3

1.2

23.82

24.87

u/l

0.07

204

1340

Disorder of external ear, unspecified

1.33

0.37

1.2

26.33

19.40

u/l

—

Other degenerative diseases of the nervous system

589

1.10

0.37

1.3

1.2

26.89

29.93

u/l

0.18

496

Other sexually transmitted chlamydial diseases, including avohilmo

134

1.27

0.36

1.1

1.2

13.58

23.41

u/l

0.69

120

Acute appendicitis

224

1961

1.06

0.36

1.3

29.87

24.97

u/l

0.50

190

1653

Pain associated with micturition

309

1.17

0.36

1.2

11.39

22.45

u/l

2.49

254

Postmenopausal bleeding

114

548

1.09

0.36

1.2

26.94

25.35

u/l

0.09

456

Acute appendicitis, with complications

534

0.88

0.36

1.3

1.2

54.00

23.19

u/l

1.04

443

Contact with nonpowered hand tool

0.65

0.35

1.0

1.2

7.60

17.94

u/l

—

Chronic laryngitis and laryngotracheitis

395

1.14

0.34

1.2

20.03

22.70

u/l

0.21

321

Tuberculosis of other organs, strict

1.37

0.34

1.5

1.2

36.17

24.54

u/l

—

Appendicitis, broad definition

239

2033

1.05

0.34

1.3

28.53

25.16

u/l

0.34

205

1712

Other melanin hyperpigmentation

1.34

0.34

1.3

1.2

15.83

19.03

u/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.34

0.33

1.0

1.1

21.50

20.84

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

377

1.14

0.33

1.2

14.31

21.91

u/l

0.96

321

Mental and behavioural disorders due to cannabinoids

1.33

0.33

1.0

1.3

12.83

12.87

u/l

—

Glaucoma, exfoliation

275

0.84

0.33

1.1

1.2

50.75

25.56

u/l

0.85

219

Tuberculosis of other organs, strict, including avohilmo

1.31

0.33

1.5

1.2

36.17

25.08

u/l

—

Ectopic pregnancy

530

0.89

0.33

1.1

1.2

11.41

21.97

u/l

2.62

437

Use of levodopa decarboxylase inhibitor

350

1.14

0.32

1.4

1.2

22.55

26.82

u/l

0.26

285

Myopia

285

0.84

0.32

1.4

1.2

18.74

22.15

u/l

0.23

241

Diseases of appendix

240

2040

1.05

0.31

1.3

28.42

25.13

u/l

0.33

206

1718

Complications predominantly related to the puerperium

716

0.91

0.31

1.4

1.2

16.61

21.65

u/l

0.68

606

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

437

1.12

0.31

1.2

46.93

21.11

u/l

1.20

354

Migraine without aura and triptan purchases

409

1.13

0.30

1.2

12.24

22.28

u/l

1.94

350

Other symptoms and signs involving the nervous and musculoskeletal systems

117

1254

0.93

0.30

1.4

1.2

34.94

23.20

u/l

0.78

1046

Acute alcohol intoxication, ICD10

457

1.12

0.30

1.1

1.2

44.77

25.03

u/l

0.81

380

Lesion of ulnar nerve

363

1.13

0.29

1.2

22.82

26.25

u/l

0.24

299

Other noninflammatory disorders of uterus, except cervix

541

1.09

0.29

1.2

20.92

24.41

u/l

0.43

450

Anti-inflammatory and antirheumatic products, non-steroids

417

1.09

0.29

1.2

31.33

26.44

u/l

0.29

372

Primary open-angle glaucoma, strict

813

0.92

0.28

1.3

1.2

27.30

28.10

u/l

0.05

665

Later onset COPD

630

1.08

0.28

1.1

1.3

24.96

32.11

u/l

1.00

517

Impingement syndrome of shoulder

661

1.09

0.28

1.2

1.3

24.23

23.36

u/l

0.06

553

therapeutic use

1.27

0.27

1.6

1.2

61.63

15.43

u/l

—

Viral meningitis

1.27

0.27

1.3

1.2

103.50

16.65

u/l

—

Other symptoms and signs involving the digestive system and abdomen

460

1.11

0.27

1.3

1.2

25.22

24.01

u/l

0.08

387

Contraceptive management

116

866

0.94

0.27

1.4

1.2

21.23

22.12

u/l

0.07

103

735

Pre-eclampsia or poor fetal growth

789

0.92

0.27

1.4

1.2

14.68

21.88

u/l

1.62

668

Puerperal sepsis

416

0.89

0.26

1.3

1.2

21.32

24.54

u/l

0.20

349

Alzheimer’s disease (Late onset), excluding more controls

271

0.89

0.26

1.1

1.3

31.59

34.39

u/l

0.08

220

Vasomotor and allergic rhinitis

113

1035

1.07

0.26

1.3

1.2

20.56

21.32

u/l

0.06

100

859

Other diseases of spinal cord

1.20

0.26

1.7

1.2

43.50

19.12

u/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.20

0.26

1.4

1.2

27.12

20.31

u/l

—

Excessive, frequent and irregular menstruation

128

642

1.06

0.26

1.2

1.3

20.10

24.33

u/l

0.52

110

537

Vascular dementia

208

1.16

0.25

1.1

1.2

54.80

31.45

u/l

0.50

172

Maternal care for known or suspected abnormality of pelvic organs

435

0.91

0.25

1.3

1.2

14.00

22.56

u/l

0.97

379

Artificial joint operation, meniscal resection

307

2035

0.96

0.24

1.2

1.3

23.23

28.12

u/l

1.23

260

1721

Female infertility

508

1.07

0.24

1.2

1.3

26.16

25.18

u/l

0.04

427

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

191

0.84

0.24

1.3

1.2

16.18

20.74

u/l

0.38

159

Traumatic amputation of wrist and hand

0.71

0.24

1.0

1.2

75.33

22.17

u/l

—

Hydrocele

246

1.14

0.23

1.1

1.3

31.79

25.84

u/l

0.25

199

Viral encephalitis, not elsewhere classified/unspecified

1.28

0.23

1.2

1.3

41.20

17.27

u/l

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

1.25

0.22

1.2

1.3

41.20

16.85

u/l

—

Viral infections of the central nervous system

153

1.18

0.22

1.2

58.56

25.59

u/l

0.33

131

Normal-pressure hydrocephalus

0.74

0.22

1.0

1.3

17.29

24.89

u/l

—

Pregnancy with abortive outcome

218

1182

0.96

0.22

1.2

26.49

23.42

u/l

0.24

188

991

Other menopausal disorders

105

551

1.06

0.22

1.2

1.3

18.35

25.58

u/l

0.71

457

Impacted maxillary canine

0.00

0.21

0.0

1.1

—

14.91

—

Parkinson's disease, strict definition, excluding more controls

294

1.11

0.21

1.4

1.3

22.97

30.80

u/l

0.46

241

Type 1 diabetes, wide definition, subgroup 2

0.00

0.20

0.0

1.1

—

16.67

—

Presence of other devices

625

0.93

0.20

1.3

1.2

25.78

28.35

u/l

0.22

513

Menorrhagia

116

613

1.06

0.20

1.2

1.3

22.14

25.14

u/l

0.29

101

511

Unknown and unspecified causes of morbidity

115

0.78

0.20

1.7

1.2

29.00

15.85

u/l

—

Atrial septal defect, secundum type

1.20

0.19

2.0

1.2

16.33

13.05

u/l

—

Organic, including symptomatic, mental disorders

177

1196

1.04

0.19

1.2

30.50

28.45

u/l

0.16

148

990

Pedal cyclist injured in noncollision transport accidents

270

1.11

0.18

1.1

1.2

25.67

28.69

u/l

0.12

224

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

134

1213

0.96

0.18

1.2

14.71

22.55

u/l

2.78

120

1024

Maternal care for known or suspected fetal abnormality and damage

295

1.09

0.17

1.1

1.3

11.09

20.67

u/l

1.84

264

Other disorders of prostate

1.11

0.17

1.7

1.2

37.43

19.88

u/l

—

Carcinoma in situ, bladder

0.72

0.17

1.2

17.60

23.86

u/l

—

Other obstetric trauma

1.20

0.16

1.3

18.82

33.44

u/l

0.42

Lichen sclerosus et atrophicus

351

1.08

0.15

1.1

1.2

24.20

24.67

u/l

0.01

288

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

359

0.92

0.15

1.1

1.2

15.88

24.03

u/l

0.96

294

Supervision of normal pregnancy

323

0.94

0.15

1.2

1.3

12.59

20.81

u/l

1.36

287

Parkinson's disease, excluding more controls

323

1.08

0.15

1.3

22.03

32.30

u/l

0.71

266

Pre-eclampsia

544

0.94

0.15

1.3

1.2

16.61

22.35

u/l

0.82

454

Hypertrophy of breast in women and men

585

1.06

0.15

1.2

13.29

23.59

u/l

1.95

490

Coxarthrosis, primary, with hip surgery

164

1470

1.03

0.15

1.3

1.2

29.24

26.05

u/l

0.21

136

1221

Diabetes mellitus in pregnancy

464

1.05

0.15

1.4

1.3

17.07

25.02

u/l

1.00

399

Lichen ruber planus, wide definition including periferal and oral lichen planus

722

1.05

0.15

1.3

1.2

32.80

25.01

u/l

0.44

591

Other benign neoplasms of skin

123

1183

1.04

0.15

1.4

1.2

25.09

25.40

u/l

0.02

104

981

Varicose veins

212

1555

1.03

0.14

1.3

1.2

28.73

26.36

u/l

0.24

175

1302

Benign neoplasm: Cerebral meninges

254

0.90

0.14

1.4

1.2

19.65

20.09

u/l

0.03

213

Gonarthrosis, primary, with knee surgery

200

1601

0.97

0.14

1.2

1.3

21.90

26.62

u/l

0.96

164

1343

Antepartum haemorrhage, not elsewhere classified

170

0.88

0.13

1.1

1.3

9.70

23.07

u/l

—

150

Aneurysms, operations, SAH

449

0.94

0.13

1.2

17.64

23.15

u/l

0.81

369

Irregular menses

156

1135

1.03

0.13

1.2

17.00

21.84

u/l

1.15

137

957

Cervicobrachial syndrome

608

1.05

0.13

1.1

1.3

32.13

24.47

u/l

0.35

503

Anomalies of dental arch relationship, including avohilmo

442

0.94

0.13

1.3

1.2

29.68

22.24

u/l

0.34

377

Disorders of refraction and accommodation

782

1.04

0.12

1.3

1.2

29.72

20.83

u/l

0.34

655

Unspecified abortion

133

1.13

0.12

1.5

1.1

22.93

20.49

u/l

0.08

109

HSIL lesion of the cervix uteri, vagina or vulva

477

0.94

0.12

1.2

34.82

19.33

u/l

0.41

405

Hypertrophy of breast

522

1.05

0.12

1.2

13.24

23.84

u/l

1.69

438

malignant neoplasm of female genital organs

415

1.06

0.11

1.3

1.2

29.35

20.60

u/l

0.58

347

Polycystic ovarian syndrome, consortium definition

257

1442

1.02

0.11

1.2

21.04

23.50

u/l

0.37

222

1219

Peritonsillar abscess

486

0.95

0.11

1.2

43.49

21.32

u/l

0.51

399

Allergic rhinitis

798

1.04

0.11

1.2

20.78

19.92

u/l

0.05

672

Endometriosis of pelvic peritoneum

432

0.95

0.11

1.2

1.3

18.82

26.41

u/l

0.57

362

Other abnormal uterine and vaginal bleeding

561

0.96

0.10

1.3

1.2

27.23

24.15

u/l

0.19

465

Glaucoma suspect

125

1213

1.03

0.10

1.2

18.57

24.93

u/l

1.67

101

999

Benign leiomyoma with endometriosis

505

1.05

0.10

1.3

1.2

27.02

23.36

u/l

0.13

416

Primary coxarthrosis, bilateral

911

0.97

0.10

1.3

1.2

21.73

26.54

u/l

0.84

741

Pedal cyclist injured in transport accident

594

1.04

0.10

1.4

1.2

19.90

23.79

u/l

0.41

497

Parkinson's disease, including avohilmo

402

0.94

0.10

1.3

1.2

22.03

25.83

u/l

0.22

327

Other disorders of ear

314

2062

0.98

0.09

1.3

1.2

26.42

27.00

u/l

0.05

266

1740

Circumscribed brain atrophy

1.09

0.09

1.4

1.3

70.80

20.30

u/l

—

Malignant neoplasm of ovary, including Hilmo

145

1.10

0.09

1.4

1.2

27.81

16.55

u/l

0.51

119

Endometriosis

110

621

1.03

0.09

1.2

24.32

24.85

u/l

0.02

520

Other and unspecified degenerative diseases of nervous system

1.11

0.09

1.8

1.3

74.33

29.69

u/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.09

0.09

1.7

1.2

25.33

37.07

u/l

—

Burn and corrosion of trunk

1.09

0.09

1.3

1.2

10.83

16.42

u/l

—

Moderate visual impairment, binocular

1.09

0.09

1.2

11.83

16.86

u/l

—

Nontraumatic intracranial haemmorrhage

532

0.96

0.08

1.3

1.2

20.77

27.15

u/l

0.67

435

Chondromalacia

1.03

0.08

1.0

1.2

49.33

17.43

u/l

—

Nontoxic multinodular goitre

597

1.04

0.08

1.3

1.2

14.91

24.89

u/l

1.41

496

Serous carcinoma of ovary, including Hilmo

0.77

0.08

1.6

1.2

23.60

18.75

u/l

—

Acetic acid derivatives and related substances

395

1.03

0.08

1.2

1.3

27.32

27.30

u/l

0.00

351

Pain and other conditions associated with female genital organs and menstrual cycle

475

1.04

0.07

1.1

1.3

14.41

24.97

u/l

1.73

396

Benign neoplasm: Skin of ear and external auricular canal

0.81

0.07

2.2

1.2

82.33

24.67

u/l

—

Impacted maxillary molar

0.86

0.07

1.4

1.3

5.00

26.28

u/l

—

Inguinal hernia

151

1023

0.98

0.07

1.3

22.89

30.13

u/l

1.20

125

847

Benign neoplasm: Skin, unspecified

1.03

0.07

1.4

1.2

13.89

19.07

u/l

—

Endometriosis of ovary

491

1.04

0.06

1.3

40.00

26.63

u/l

0.31

401

Dislocation, sprain and strain of joints and ligaments of knee

180

1600

1.02

0.06

1.2

1.3

18.38

23.36

u/l

1.21

153

1350

Alzheimer’s disease (Early onset)

101

0.89

0.06

1.1

1.2

10.33

29.04

u/l

—

Pregnancy hypertension

118

1075

0.98

0.06

1.2

14.33

22.86

u/l

2.88

104

911

Alzheimer disease, excluding more controls

325

1.04

0.06

1.2

22.49

31.10

u/l

0.61

267

Gonarthrosis,primary

317

1893

1.01

0.04

1.2

1.3

23.95

27.92

u/l

0.78

262

1603

Other benign neoplasms of connective and other soft tissue

220

1.05

0.03

1.4

1.2

13.86

19.83

u/l

1.04

186

Triptan medication for migraine, min. 3 purchases

170

1283

0.99

0.03

1.2

17.15

22.18

u/l

1.10

143

1088

Migraine, single triptan purchase ok & required. ICD-code if available is included

245

1672

0.99

0.03

1.3

16.26

23.92

u/l

3.16

209

1419

Triptan medication for migraine, single purchase ok

245

1672

0.99

0.03

1.3

16.26

23.92

u/l

3.16

209

1419

Female infertility, associated with anovulation

108

0.93

0.03

1.3

11.60

30.45

u/l

—

Normotensive glaucoma

229

0.96

0.02

1.2

1.3

27.35

25.03

u/l

0.12

191

Medical treatment for female infertility

416

0.98

0.02

1.3

1.2

15.48

24.31

u/l

0.81

360

Endometriosis ASRM stages 1,2

461

1.02

0.02

1.2

18.20

21.34

u/l

0.20

396

Endometriosis ASRM stages 3,4

641

1.01

0.01

1.3

1.2

35.26

22.49

u/l

0.38

534

Infectious mononucleosis, including avohilmo

133

1.05

0.01

1.1

1.3

72.93

24.99

u/l

0.36

117

Infectious mononucleosis

133

1.05

0.01

1.1

1.3

72.93

24.99

u/l

0.36

117

HSIL lesion of the cervix uteri

402

1.02

0.01

1.3

1.2

34.03

20.38

u/l

0.32

341

Other female pelvic inflammatory diseases

462

1.02

0.01

1.3

1.2

20.61

23.07

u/l

0.16

383

Other condition

346

0.98

0.00

1.2

58.14

24.78

u/l

1.15

285

Parkinson's disease

386

0.98

0.00

1.3

1.2

22.03

26.17

u/l

0.25

315

Tinnitus

746

0.99

0.00

1.3

1.2

17.50

24.24

u/l

1.01

611

Schizophrenia

376

1.01

0.00

1.0

1.2

15.84

23.41

u/l

0.91

314

Benign neoplasm: Skin of eyelid, including canthus

434

0.99

0.00

1.3

1.2

14.41

25.03

u/l

2.20

361

Pre-eclampsia or eclampsia

604

0.99

0.00

1.3

1.2

15.43

23.38

u/l

1.50

505

Dysplasia of cervi uteri

483

1.00

0.00

1.2

1.3

23.64

25.32

u/l

0.05

405

Supervision of high-risk pregnancy

316

1.01

0.00

1.2

1.3

25.81

20.63

u/l

0.14

280

Other acquired deformities of musculoskeletal system and connective tissue

1.05

0.00

1.4

1.2

27.40

17.69

u/l

—

Temporomandibular joint disorders, including avohilmo

133

1290

1.00

0.00

1.2

1.3

17.16

21.88

u/l

0.89

107

1089

Other disorders of eyelid

152

1432

1.00

0.00

1.2

25.22

25.53

u/l

0.02

129

1182

Chronic suppurative otitis media

129

1.01

0.00

1.8

1.2

82.54

21.10

u/l

0.46

111

Parkinson's disease, strict definition

350

1.00

0.00

1.4

1.2

22.97

27.20

u/l

0.23

285

Failed induction of labour

0.99

0.00

1.0

1.3

7.25

27.89

u/l

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.0

—

8.67

—

Malignant neoplasm of ovary

100

1.00

-0.00

1.3

1.2

37.60

17.63

u/l

—

Birth asphyxia

0.00

-0.00

0.0

1.1

—

9.25

—

Other and unspecified mononeuropathies of upper limb

0.97

-0.00

1.2

10.33

16.15

u/l

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.1

—

13.25

—

Benign neoplasm of meninges

280

1.00

-0.00

1.6

1.2

17.57

23.29

u/l

0.44

235

Alzheimer’s disease (Early onset), excluding more controls

0.97

-0.00

1.1

1.2

10.33

23.28

u/l

—

Oral lichen planus

1.02

-0.00

1.5

1.2

80.00

14.68

u/l

—

0.00

-0.00

0.0

1.0

—

10.00

—

Subacute thyroiditis

1.01

-0.00

1.1

1.2

22.00

15.55

u/l

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

1.0

—

20.40

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.0

—

14.50

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.3

—

10.75

—

Peripheral retinal degeneration

0.86

-0.00

1.4

1.2

10.20

15.74

u/l

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.1

—

13.29

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.0

—

9.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS